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■ Abstract T cell development is guided by a complex set of transcription factors
that act recursively, in different combinations, at each of the developmental choice
points from T-lineage specification to peripheral T cell specialization. This review de-
scribes the modes of action of the major T-lineage-defining transcription factors and the
signal pathways that activate them during intrathymic differentiation from pluripotent
precursors. Roles of Notch and its effector RBPSuh (CSL), GATA-3, E2A/HEB and
Id proteins, c-Myb, TCF-1, and members of the Runx, Ets, and Ikaros families are
critical. Less known transcription factors that are newly recognized as being required
for T cell development at particular checkpoints are also described. The transcriptional
regulation of T cell development is contrasted with that of B cell development, in
terms of their different degrees of overlap with the stem-cell program and the differ-
ent roles of key transcription factors in gene regulatory networks leading to lineage
commitment.
OVERVIEW OF T CELL DEVELOPMENT AND
ITS REQUIREMENTS
T cells are the only hematopoietic cells that are not generated in the bone marrow.
Instead, virtually all circulating T lymphocytes are generated in the thymus, and
many different types exist. T cells are further distinguished among hematopoietic
cells by their potentially infinite proliferative life spans and by their capacity for
differentiative specialization even after their mature features are in place. Some of
this specialization is triggered by environmental signals from antigen recognition
and/or other ligand/receptor interactions. Thus T cell development, as a process,
incorporates multiple stages at which different choices are available to the cells,
extending over many cell cycles and a long period of time. In spite of this complex-
ity, the T cell program as a whole is unified by the identities of the key regulators
throughout the process: Many of the same regulatory factors and growth factor
receptors are used again and again at different stages. This review focuses on the
roles of these factors in establishing T cell identity as they guide uncommitted
hematopoietic precursors into, and through, thymic differentiation.
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A Map of the Terrain: Stages of T Cell Development
At least five stages have been defined in which specific regulators are needed for
T cell development to proceed. First, there is the specification process, through
which multipotent precursors first enter the T cell pathway, usually as they first
immigrate to the thymus. Second is the complex process in which proliferative
expansion and T cell receptor (TCR) gene rearrangement are combined with com-
mitment to the T lineage within the thymus. These first stages are examined closely
at the end of this review. Third is β-selection, which is a cascade of differentiation
and proliferation events triggered specifically by “pre-TCR” signaling in precur-
sors of TCRαβ T cells, after successful rearrangement of the TCRβ gene. Fourth is
TCR-dependent positive selection, a major physiological transition, which is cou-
pled with developmental divergence between CD4 and CD8 lineages of T cells.
Fifth is the continuing differentiation of T cells in the periphery, which occurs
upon stimulation with antigen, antigen-presenting cells, and cytokines. This has
been most closely studied for the divergence of Th1 and Th2 CD4 cell types. These
stages are diagrammed in Figure 1.
The β-selection and positive selection checkpoints make production of mature
T cells depend on successful rearrangement of the T cell receptor genes, either
TCRγ and TCRδ or TCRα and TCRβ. Rearrangement is made possible by the
expression of the linked RAG-1 and RAG-2 recombinase genes and by the accessi-
bility of the TCR-coding loci in chromatin at the appropriate stages. Transcriptional
induction of RAG genes and transcription factor-mediated opening of the TCR loci
thus constitute aspects of T cell specification. TCRγ , δ, and β rearrangement all
occur during the early DN (double negative) stages (Figure 1), whereas TCRα
rearrangement is only permitted in cells that have reached the DP (CD4+ CD8+
TCRlow) stage. The cell can sense the success of these rearrangements in encoding a
translatable protein because there is also transcriptional activation of the genes en-
coding the signaling components of the TCR complex, from the earliest stages, and
these proteins enable products of newly recombined TCR genes to assemble into
functional signaling complexes. Successful TCRβ rearrangement entitles the cell
to pass through the β-selection checkpoint and become eligible for differentiation
→
Figure 1 Outline of T cell development: landmark stages, checkpoints, and devel-
opmental choices. Right side: cell-surface markers used in combination to distinguish
specific developmental stages. DN: double negative for CD4 and CD8, and as used in
this figure, implied to be negative for cell-surface T cell receptor complex expression
as well. TCRγ δ and NKT cells are also commonly CD4− CD8− but are mature TCR+
subsets that are presented separately. DN1, DN2, DN3, and DN4 stages of DN cell
differentiation are distinguished by CD44, c-Kit, and CD25 expression as indicated.
DP: CD4+ CD8+ TCRαβ-low. CD4 SP: CD4+ CD8− TCRαβ-high. CD8 SP: CD4−
CD8+ TCRαβ-high. Branch points from the TCRαβ mainstream for NKT and T-reg
lineages of TCRαβ cells are incompletely defined.
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in the TCRαβ lineage, including the activation of TCRα gene rearrangement. As
an alternative to β-selection, successful rearrangement of TCRγ and TCRδ to-
gether enables the cell to differentiate as a TCRγ δ cell instead. Cells failing at
both will die. Only after successful generation of a TCRαβ receptor with appropri-
ate specificity are TCRαβ lineage cells able to pass through a second checkpoint,
i.e., positive selection, and then complete their maturation.
TCR-dependent signaling in thymocyte development not only determines sur-
vival versus death, but also acts more subtly in other kinds of lineage choice, as
discussed in recent reviews (1–5). The quality of signaling at these checkpoints
can have a strong influence on the choice of developmental paths that follow. A
particularly clear case is at positive selection, when the strength and duration of
signaling induced by TCR/ligand interaction in the thymus not only determines
which cells will be positively selected, but also guides them to differentiate into
either CD4 T cells or CD8 T cells (3–5). For the purposes of this review, most
notable about these TCR-dependent events is how very similar signals, from vari-
ants of the same receptor, trigger radically different regulatory consequences. In
positive selection, for example, this trigger is a transient interaction, and yet CD4
cell and CD8 cell positive selection processes elicit divergent developmental cas-
cades that result in numerous long-term differences in mature cell function and
effector potential, which will be maintained through many cell divisions in the
periphery. The TCR-dependent program that governs TCRγ δ cell development is
also remarkably different from the β-selection response, and the consequences of
pre-TCR triggering at β-selection are also quite different from the consequences
of TCR triggering at positive selection, as reviewed elsewhere (6).
The explanations lie in the different transcription factor genes that are specif-
ically induced under different conditions (5), and the regulatory context that in-
fluences which of these genes will be available for activation by a given signal.
Thus in this review, we do not focus on the differences among the various trigger-
ing signals as such, but instead, review the regulatory basis for the fundamentally
different developmental programs (TCRγ δ development, β-selection, CD4 cell
maturation, and CD8 cell maturation) that they call into play. A remarkable frac-
tion of the regulatory molecules involved in these choices also play roles in T cell
development from the earliest stages.
The genetic manipulation approaches that have been most powerful for dissect-
ing regulatory relationships are much more accessible in the mouse than in human
systems, and so most of this review is based on results in the murine system. How-
ever, where evidence is available, human T cell development appears to depend on
the same regulators, and some clues suggest that the roles of key factors in T cell
development may be broadly conserved among jawed vertebrates.
Critical Regulators: Introductory Overview
Gene knockout experiments have shown that T cell development depends from
its earliest stages on at least a half dozen transcription factors, one “instructive”
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signaling system, and at least three other signaling systems used for growth and
survival at particular points. Nearly all of these regulators play ongoing roles in
T cell development, although their specific effects shift from one stage to another.
They are introduced briefly here, and in the following sections, the roles of each
of the transcriptional regulators are discussed in detail.
T cell gene expression and even the first recognizable stages of T cell develop-
ment depend on the transcription factors GATA-3, c-Myb, members of the Runx
family, members of the E2A/HEB family, and members of the Ikaros family. In
fetal life, appearance of specified pre-T cells also depends on the Ets-family tran-
scription factor PU.1. Most of these factors are needed for other hematopoietic
fates besides the T cell fate. Hunchback-class zinc finger factors of the Ikaros
family are needed for all lymphocyte lineages, and the E2A/HEB class of bHLH
transcription factors is absolutely essential for B cell development as well as for
T cell development. Other factors, such as c-Myb, PU.1, and Runx1, are required
to generate the multipotent hematopoietic progenitors of T cells, in addition to
playing specific roles in early T cell functions proper. The one transcription factor
that appears to be T cell specific is GATA-3. However, this too is a close relative
of the stem-cell factor GATA-2. The ability of these molecules to turn on T cell
genes as opposed to non-T cell genes is therefore likely to represent target-gene
specificity emerging from combinatorial transcription factor action.
T cell development also depends on two other transcription factors that represent
dedicated effectors of cell-surface receptor signaling, TCF-1 (Tcf7) and RBPSuh
(a.k.a. RBP-Jκ , or CBF/Suppressor of Hairless/Lag-1 = CSL). These factors are
distinctive because they are repressors by default but are changed into activators by
signaling cascades in response to environmental signals. TCF-1 is the effector of
the Wnt/frz/β-catenin signaling cascade, and RBPSuh is the effector of the Notch
signaling cascade. The exact roles that these factors play in T cell development
appear to be different, as described below, but they share the critical feature that
their presence in the precursors of T cells imposes a dichotomous switch-like
behavior on every function they control. The same genes that they activate in the
presence of a signal, they repress in the absence of a signal. The Notch signaling
cascade is the unique “instructive” signaling system used for T cell specification,
whereas the Wnt/TCF signaling system has an important role in proliferation
coupled with differentiation.
Other genes that are essential for T cell development encode cytokine recep-
tors as well as pre-TCR/TCR components that are needed for survival and pro-
liferation. Early in T cell development the IL-7 receptor complex (IL7Rα/γ c =
CD127/CD132) is most important, while survival and proliferation are dominated
later by signals from different versions of the TCR complex (pre-TCR, TCRγ δ,
or TCRαβ associated with CD4 or CD8 coreceptors). These signal-dependent re-
ceptors all differ from the Notch system in that they primarily trigger the de novo
appearance or nuclear localization of transcription factors, rather than conversion
of a repressor to an activator. They thus lend themselves more to promoting graded
responses, such as proliferation and activation, rather than the kinds of all-or-none
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dichotomous effects of Notch/RBPSuh. The transcription factors mobilized in-
clude STAT5, NF-κB, NF-AT, and AP-1 in different combinations, with greater
or lesser contributions from the PI-3 kinase, Akt/PKB, and Ras/MAP kinase sig-
naling pathways (see 1–5). The survival and proliferative (trophic) effects of these
receptor systems are well explained by the activation of these mediators.
Triggering of cytokine receptors, like the triggering of TCR complexes, can
also have developmental effects that are specific to different stages. Whereas the
receptors are lineage-specific in their expression, the factors they activate are not.
Without minimizing the importance of these pathways, the developmental conse-
quences of their triggering must be heavily influenced by changes in the “regula-
tory contexts” within which they are activated. In this review, therefore, we focus
primarily on the transcription factors themselves and the transcription-linked sig-
naling systems that set these different regulatory contexts.
REPERTORY PLAYERS: T CELL IDENTITY FACTORS IN
RECURRENT ROLES
A particular set of T cell transcription factors and signaling molecules is used
repeatedly throughout T cell development to establish T cell identity and then to
make choices between successive T-lineage subspecializations. These recurrent
players include Notch molecules and their direct transcriptional effector RBPSuh
(CSL); GATA-3; the bHLH factors E2A and HEB and their antagonists Id2 and Id3;
Runx1 and Runx3; and possibly also members of the Ikaros family. These factors
can be viewed as central to T cell identity, somewhat analogous to the B cell factors
EBF and Pax5 (7), which are compared in more detail below. However, in the case
of T cell development, the individual functions that these factors perform are
discontinuous, stage-specific, and even subject to alternation between activating
and inhibitory effects from one stage to the next. These “identity factors” are
described here in detail.
Notch and its Mediators
The transmembrane signaling receptor Notch1 is a representative of an ancient,
evolutionarily conserved family of developmental regulators that was first noted
for its importance for neurogenesis in embryos of Drosophila melanogaster. In
the mouse, Notch1 is essential for embryonic viability also, and it is expressed at
a particularly high level in the thymus. In the late 1990s, Notch gain of function
was shown to have powerful influences on TCR-dependent selection events in
the thymus. Then with the advent of conditional knockout technology, it became
possible to remove Notch1 function, and this revealed that T cell development
is intensely and specifically dependent on Notch1 in the pluripotent precursor
stage (reviewed in 8–10). Without Notch1, precursors cannot develop into T cells
at all, and B cells develop in the thymus instead. At the same time, retroviral
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Figure 2 Roles of Notch and its transcriptional effectors in T cell specification and devel-
opmental choices. Stages at which T cell development is affected by gain or loss of function
of Notch1, other Notch proteins, or the Notch transcriptional mediator RBPSuh (CSL) are
indicated. See text for details and review citations.
transduction of constitutively active Notch (Notch1IC) into pluripotent precursors
showed that Notch gain of function could also enhance T cell development while
blocking B cell development (Figure 2). As noted above, one major pathway of
Notch signaling involves cleavage of the Notch cytoplasmic domain to generate
a transcriptional activation domain, which migrates to the nucleus and converts
a default repressor, RBPSuh, into an activator. Knockout experiments indicate
that this is the pathway through which Notch promotes T cell development and
suppresses B cell development (11, 12). Notch1/RBPSuh are the first, and so far
the only, regulators in which gain and loss of function have been shown to have
simple reciprocal effects on initial T cell specification.
Notch family molecules also play more complex roles later, both in TCR-
dependent selection events and in peripheral T cell differentiation. Conditional
knockout studies with deletion in intrathymic DN cells have shown that Notch1
is needed for TCRβ gene rearrangement; also, in vitro assay systems show that
Notch/Delta interactions are needed to sustain T cells through the proliferation
and differentiation events of β-selection, complementing signals from the pre-
TCR (13–16) (Figure 2). Deletion of RBPSuh between T-lineage specification and
β-selection favors development of TCRγ δ lineage T cells at the expense of TCRαβ
T cells (12) (Figure 2). Normally, Notch1 and the genes that it immediately acti-
vates are expressed at the highest levels in DN (double negative) thymocytes prior
to β-selection, and substantially downregulated thereafter (14, 17). Constitutive
expression of activated Notch perturbs the gene expression setpoints in DP (double
positive) cells that emerge from β-selection (14, 18) and can lead to leukemias that
resemble cells frozen in mid-β-selection (19–21). Thus, not only Notch activation
but also its correctly regulated deactivation are important to generate the pool of
TCRαβ+ thymocytes from which positive selection and maturation will occur.
Alterations of Notch activation in thymocytes at later stages can sharply perturb
positive selection and the CD4/CD8 lineage choice as well (Figure 2). However,
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the exact effects seen vary substantially in different experimental tests (reviewed
in 8–10, 22–24). In overexpression studies the result depends on the exact form
of the constitutively activated Notch molecule, since the intracellular domain of
Notch contains a number of separate domains mediating interactions with differ-
ent coeffectors (see reviews, above). Most gain-of-function studies have shown an
enhancement of CD8 cell development, though this is not uniform, and whether
this is due to trophic effects, alteration of signaling, or developmental program-
ming is subject to debate. Loss-of-function studies have been complicated by the
ability of multiple Notch family members to contribute to thymocyte responses at
these late stages and by uncertainties about the specificities of pharmacological
inhibitors of Notch signaling and the exact modes of action of endogenous sig-
naling modulators. Also complicating the interpretation of all the transgenic and
knockout experiments is an intrinsic aspect of thymocyte population dynamics,
namely the small number of cell division cycles between the end of β-selection
and the start of positive selection. This means that Notch manipulation might affect
positive selection indirectly through perturbations of the β-selection process, and
its impact may appear different in kinetic than in steady-state analyses.
Some clarification may emerge eventually from identification of the ligands for
Notch during positive selection. Notch receptors interact with two different kinds
of ligands, Delta-like and Jagged family molecules, and although they both acti-
vate RBPSuh, they promote distinct developmental responses through additional
pathways that are still under investigation (25–27). Very recently, it has emerged
that the differential signaling capacities of Notch family members interacting with
Delta-like versus Jagged family ligands are probably quite significant in peripheral
T cell differentiation (Figure 2). Differential uses of these classes of Notch lig-
ands, and perhaps Notch family members, in contacts between mature peripheral
T cells and antigen-presenting cells, act as instructive signals to bias the subse-
quent differentiation of the T cells into specialized effectors of the Th1, Th2, or
T-reg classes (27–30). Although RBPSuh seems to have a direct involvement in the
Notch/Jagged pathway that favors the Th2 fate, other Notch/Delta-like signaling
pathways appear to contribute to the Th1 fate (27). Thus Notch signaling underlies
a succession of divergent choices in T cell differentiation that continue long after
its initial role in T- versus B-lineage specification.
GATA-3
GATA-3 is the one transcription factor that appears to be expressed in a completely
T cell–specific way among all hematopoietic cell types. While it is also needed
for many nonhematopoietic cell types, and GATA-3 mutants do not survive mid-
gestation, the only hematopoietic effects seen are a reduction in hematopoietic
progenitor cells, complete loss of T cell development, and a late defect in the final
maturation of NK cells (31–33). GATA-3 expression rises as T-lineage differen-
tiation begins (T. Taghon, E.-S. David, J.C. Zu´n˜iga-Pflu¨cker & E.V. Rothenberg,
submitted; 34) and peaks in the thymus during the proliferation at β-selection
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Figure 3 Roles of GATA-3 in support of T cell development. Stages at which loss of GATA-
3 function affects T lineage differentiative progression and developmental choices are shown
with the implied direction of the normal GATA-3 effect as indicated. Within the T lineage,
overexpression of GATA-3 or a GATA-3 hypomorphic mutant has similar effects to those
indicated; however, in prethymic precursors, GATA-3 overexpression causes a paradoxical
deviation away from all lymphoid fates (not shown in figure).
and again, later, in cells undergoing positive selection to the CD4 SP thymocyte
fate (32, 35, 36). Expression drops again in resting peripheral T cells, but can be
reinduced specifically upon antigen activation. GATA-3 plays critical functional
roles in all of these stages, as summarized in Figure 3.
GATA-3 is implicated in regulating the genes that are needed in multiple stages
of T cell development, from intrathymic targets such as RAG-2, TCR gene en-
hancers, and CD8, to the peripheral T cell effector IL-4 (37–41). Germline knock-
out experiments show that it is critical for the generation of any identifiable T cell
precursors, either in vivo (in chimeras) or in vitro. Conditional knockout experi-
ments, which delete GATA-3 only after the cells immigrate to the thymus, show
that it is also needed for normal β-selection and proliferation in the DN to DP
transition (36). Then it has a prominent role at positive selection, promoting the
development of CD4 SP cells and blocking the development of CD8 SP cells (35,
36, 42). In peripheral T cells, it modulates cell survival and migration behavior
(43) and plays a dominant role in the differentiation of CD4 T cells to a Th2 fate
(reviewed in 44, 45).
In spite of its vital regulatory involvement in T cell developmental progression,
GATA-3 is not a simple equivalent of dominant lineage regulators like erythroid
GATA-1 or B cell EBF or Pax5. Forced expression of GATA-3 in nonthymic
hematopoietic precursors does not enhance or accelerate T cell specification. In-
stead, it completely aborts T cell specification, and this shocking result is a consis-
tent finding both in vivo and in vitro (T. Taghon, M. De Smedt, T. Kerre, J. Plum,
E.V. Rothenberg & G. LeClercq, submitted for publication; T. Taghon & E.V.
Rothenberg, in preparation; 46, 47) (Figure 3). These severely discordant results
for gain and loss of function of GATA-3 are a hallmark of the T cell specification
process (discussed below). If retroviral transduction is used to elevate GATA-3
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expression later, in thymocytes, it continues to show inappropriately inhibitory
effects, although GATA-3 effects on developmental choice at these later stages at
least display the same sign as indicated in loss-of-function studies (35, 42, 47, 48).
In mature peripheral T cells, on the other hand, gain and loss of function of GATA-
3 give concordant results for the role of this factor in the Th1/Th2-lineage choice
(44, 45, 49–51). This implies that T cell development not only relies repeatedly on
GATA-3 but also continually adjusts the regulatory context of the cells to become
more and more tolerant of GATA-3 at a wide range of doses.
A possible explanation for the difficult behavior of GATA-3 is that, like other
GATA factors, it can have a wide range of biochemically distinct activities (40, 52,
53). It can carry out chromatin remodeling (IL-4), overt transcriptional activation
(IL-5), and repression (IFNγ ). Although the mechanisms through which GATA-3
represses are poorly characterized (54, 55), one mechanism is suggested by the
presence of functional GATA-3 sites intermixed with SATB1 sites in a nuclear
matrix attachment region of the CD8 locus, i.e., a locus that is turned off when
GATA-3 expression promotes CD4 cell development (41). Different domains of
the GATA-3 molecule are implicated in these different activities (52, 56, 57),
supporting the idea that distinct functions are based on interactions with different
sets of collaborating factors. This makes it plausible that developmental changes
in the expression of other specific, potentially collaborating factors during T cell
maturation could gradually disfavor access to non-T cell genes and protect critical
T cell genes from inappropriate actions of GATA-3.
One intriguing potential cofactor for GATA-3 could be FOG-1, better known
for its cooperative role with GATA-1 during erythrocyte and megakaryocyte dif-
ferentiation. FOG-1 is expressed within the thymus and required for normal T cell
development, since FOG-1-deficient thymocytes are unable to progress through
β-selection (58), when GATA-3 activity levels appear to be high. However, it is still
unclear how FOG-1 behaves in this setting as a GATA-3 cofactor. FOG-1 can in-
hibit GATA-3 activity in a Th2-promoting assay (58, 59), and thus its potential role
might involve reducing GATA-3 activity at specific stages of T cell development.
Titration of FOG-1 could potentially explain the toxicity of high level GATA-3
expression at an early stage. In any case, it is striking how subtly GATA-3 must
be deployed during the time of its most critical T cell role, at the start of T cell
development.
E2A/HEB
T cells share with B cells a reliance on type I bHLH transcription factors (E pro-
teins) for their development from an early stage (60–62). Thymocytes express not
only E2A, the family member that is most important in B cell development, but
also the closely related factors HEB (Tcf12) and E2-2 (Tcf4) (63). A number of
T cell target genes are known to be positively regulated by this class of factors,
including CD4 and the surrogate light chain gene pTα (64–66), and E protein
binding sites are prominent in regulatory elements of RAG-1/RAG-2 recombinase
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genes that are active in DN stages and in TCR gene enhancers. E2A also pro-
vides a unique survival function in conjunction with IL-7-dependent growth (67).
Moreover, E2A/HEB dimers appear to act as positive regulators for another critical
T cell transcription factor, GATA-3 (68).
Thus it is not surprising that forced expression of any of the Id factors (Idb,
inhibitors of DNA binding), which heterodimerize with E2A-class bHLH factors
to block their DNA binding, completely aborts early T cell specification (69,
70). In fact, forced expression of Id proteins can direct precursors into the NK
lineage instead, a developmental pathway that in normal conditions is completely
dependent on the Id2 gene (63). The E proteins are therefore among the essential
directors of T-lineage development, and the balance between E protein and Id
activity in multipotent precursors is critical to arbitrate the lineage choice between
T/B and NK/DC/myeloid fates, as discussed below.
The functions of E proteins are discontinuous, however, even within the thymus
(Figure 4). E2A in particular is most essential prior to the DP stage (71). Domi-
nant negative mutants of HEB that interfere with all E proteins also block T cell
development, no later than the DN to DP transition (72). However, as T cell pre-
cursors pass through alternating periods of proliferative expansion (DN2), stasis
(DN3), and reactivation (DN4/ISP), E protein activation alternates with periods of
inhibition, as pre-TCR- or TCR-triggered activation results in waves of Id3 induc-
tion that are functionally important for the success of selection (73–75). While Id
proteins can support proliferation and other activation responses (76), E proteins
actively promote G1 arrest at developmental checkpoints (77). Thus, although the
loss of E protein function blocks T cell development completely, overexpression
of E proteins in experimental systems does not perceptibly drive precursors into
the T cell pathway.
Figure 4 Roles of Runx factors and the E protein/Id ratios in T cell development. The
figure combines data for stages of action by Runx1 and Runx3, and the roles of Id2 and Id3
as antagonists of the E2A and HEB (E protein) bHLH factors. Note the alternating phases of
E protein and Id dominance that are required for T cell development and the roles of Runx
factors acting parallel to GATA-3 at β-selection and in opposition to GATA-3 at positive
selection (see Figure 3).
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NONLINEAGE-SPECIFIC REGULATORS WITH
ESSENTIAL ROLES IN T CELL SPECIFICATION
The context in which the T-lineage identity factors operate is greatly affected by
the action of additional factors of different structural groups. These other factors
are just as critical for the generation of T cells as those discussed above, but they
are not yet shown to be implicated in the T-lineage choice as compared with other
cell fates. However, these factors continue to play important roles at specific choice
points within the T lineage.
Runx Factors
The three mammalian Runx factors are all expressed in the thymus and used
throughout T cell development, although they are not T cell specific in expression
or function (reviewed in 78, 79). GATA-3 and Runx3 are probably associated with
thymocyte differentiation throughout the jawed vertebrates, as shown by the high-
level coexpression of these factors specifically in the thymus of the cartilaginous
fish Raja eglanteria (80). The most abundant Runx factor in the thymus (Runx1) is
expressed as a legacy from hematopoietic stem cells, where it plays an indispens-
able role (81, 82). This early role dominates the phenotype of Runx1 germline
knockout animals, since there is no development of any kind of lymphocytes
when generation of definitive hematopoietic precursors is blocked. However, evi-
dence from conditional Runx knockouts, domain-specific Runx knockouts, Runx
transgenics, and regulatory mutations in specific T-lineage target genes together
unambiguously indicates that Runx factors play specific, central roles in positive
and negative gene regulation within the T cell differentiation program (79, 83–88).
Runx factors promote DN cell expansion and β-selection, expression of CD8 in
the DN to DP transition, and the selection and maturation of CD8 SP cells (Figure
4). The mechanisms involved may be complex, since thymocytes express a variety
of splice and promoter-use isoforms of Runx genes that are predicted to encode
functionally heterogeneous proteins (84, 89, 90).
Runx factors are poor transactivators alone, but capable of activating when they
collaborate with partners binding to the same cis-regulatory module, such as Ets
family factors or c-Myb. In the TCRα and TCRβ cis-regulatory elements, Runx/Ets
collaboration provides essential positive regulatory function, while Runx/Myb col-
laboration activates the TCRγ and TCRδ cis-regulatory elements (91–96). Runx
factors also provide substantial repressor activity at other target sites, recruit-
ing Groucho/TLE/Grg family proteins or Sin3A by interaction with different C-
terminal domains, and this is also important in T cell development. Runx1 activity
in the expansion and differentiation of DN thymocytes depends, at least in part,
on the Groucho-interaction domain (83).
Two specific targets of Runx repression have been analyzed in elegant detail.
The CD4 gene turns out to be silenced by Runx1 in late DN thymocytes, be-
fore β-selection, and by Runx3 in CD8 SP thymocytes, after positive selection
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(84–86). Furthermore, Runx-dependent repression appears to be important for
correct regulation of the RAG-1/2 locus (97). The mode of action in the case of
RAG-1/2 is interesting because it imposes a default condition of repression, start-
ing at β-selection, which is conditionally alleviated by factors binding a distal
“antisilencing element.” This element is specific for permitting expression in DP
thymocytes, and it is active only until positive selection occurs. If there must be a
DP-specific mechanism for antagonizing Runx repression, this implies that Runx
factors are present and active throughout the DP stage, as well as in DN and SP
thymocytes.
Evidence now accumulating indicates that Runx factors (most likely Runx3)
probably have a positive role in CD8 SP cell maturation (Figure 4), beyond their
ability to repress CD4 (85, 88, 98, 99, 99a). Exactly how this works is not yet known.
When overexpressed from the DN stage, any of the three Runx family members
appears to accelerate β-selection to the CD8+ ISP stage, but then to block the CD4
expression that normally results in a DP phenotype (84, 87). It is not clear whether
the strong Lck-dependent signals needed to induce positive selection to the CD4
lineage can be delivered to the cells in the face of this global CD4 repression. Thus
Runx factors might drive positive selection toward the CD8 SP pathway not only
through their positive effects on CD8 and their negative effects on CD4, but also
through the indirect consequences of these alterations on strength of Lck signaling.
Even independently of CD4 expression, TCR specificity, or duration of signaling,
however, Runx3 appears to promote CD8 SP lineage development, suggesting a
central role in developmental programming of cytolytic T cells (99a; T. Sato, S.-i.
Ohno, T. Hayashi, C. Sato, K. Hayashi, K. Kohu, M. Satake & S. Habu, submitted
for publication; Sonoko Habu, personal communication).
The reciprocal effects of Runx and GATA-3 in CD4/CD8 differentiation raise
the question of whether these factors antagonize each other during positive se-
lection. So far, one report (100) suggests that forced expression of Runx blocks
GATA-3 upregulation in peripheral T cells and thus biases the Th1/Th2 choice
against the Th2 fate. However, both GATA-3 and Runx1 are needed for efficient
β-selection. The mechanisms through which GATA-3 and Runx factors could
interact in the thymus remain to be explored.
Ikaros Family Transcription Factors
Ikaros and its family members were the first transcription factors found to be essen-
tial for lymphocyte development, as distinct from development of other hematopoi-
etic cell types (reviewed in 101). At least three members of the family are expressed
in the thymus, in part continuing expression from earlier hematopoietic precursors.
Ikaros itself is essential for B cell and fetal T cell development, and inhibition of
the whole family by dominant-negative transgene expression eliminates T and NK
cell development as well. While many hematopoietic genes possess Ikaros binding
sites, there has been controversy about the mode of action of this regulator and
whether it is predominantly activating or repressive (102, 103; reviewed in 104).
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Much remains unresolved about the exact ways in which it interacts with the inputs
from other lymphoid transcriptional regulators. However, the Ikaros family factors
are demonstrably important at a number of successive stages: hematopoietic stem-
cell maintenance, development of common lymphoid progenitors, β-selection and
activation of CD8 expression, and the setting of thresholds for mitogenic activation
of immature and mature T cells (103, 105–108). Recent data suggest that Ikaros
could also have a role in determining when strong TCR signaling should lead to
negative selection, rather than to CD4 SP positive selection (109).
One Ikaros family member, Helios, is expressed selectively in stem cells and in
cells of the T cell lineage, with increasing expression during T cell specification
and decreasing expression during B cell development. T-lineage-specific Helios
expression is conserved, like GATA-3 and Runx3 expression, from mammals to
cartilaginous fish (80). This suggests that Helios could play an important and
specific role in T cell development, but the functional data needed to address this
question are lacking.
At positive selection, the effects of Ikaros and the effects of Runx factors appear
to be exerted in the same direction, generally facilitating CD8 expression and/or
CD8 cell differentiation (85, 86, 88, 103). The ability of Ikaros factors to asso-
ciate with chromatin-remodeling complexes (104) could be implicated in these
actions, since the chromatin-remodeling component Brg appears to participate in
some of the same regulatory events (110). Thus, future genetic and biochemical
evidence may reveal that the driver of the positive actions of Ikaros factors in T cell
development could be a complex involving Ikaros, together with Runx and Brg
proteins.
Critical Growth-Promoting Factors: TCF/LEF-1
TCF/LEF factors, the nuclear effectors of the Wnt pathway, are essential both
at β-selection and at an earlier stage of IL-7-dependent expansion in the DN1
to DN2 transition (111–114). TCF-1 (Tcf7) is one of the most highly expressed
transcription factors in developing thymocytes (E.-S. David & E.V. Rothenberg,
unpublished data), with partially redundant expression of a closely related fac-
tor, LEF-1, in the fetal thymus. Antisense oligonucleotides against TCF-1 inhibit
T cell generation from prethymic progenitors in fetal thymic organ culture (34).
Normally, TCF-1 is converted from a repressor to a transcriptional activator by
interaction with β-catenin (or the related protein plakoglobin), and it is the acti-
vating roles of TCF-1 that appear to be most important for T cell development,
based on genetic manipulations of the TCF-1/β-catenin interaction interface (114).
However, these effects appear primarily to reflect an essential role in proliferation,
which is normally very extensive in T cell development, rather than in lineage
decisions per se (115). Members of the TCF family including TCF-1 itself are
shared between developing T cells and adult hematopoietic stem cells, where they
play important roles in proliferation prior to differentiation (116). In mice, TCF-
1 becomes increasingly important as a function of age for the waves of T cell
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precursors that differentiate after birth, in order for these cells to reach the DN2
stage (112).
c-Myb
The proto-oncogene c-Myb is also essential for T cell development, as well as
essential for B cell development and for definitive hematopoietic stem-cell gener-
ation (117–119). Molecular evidence indicates complex, context-dependent roles
for c-Myb in c-Kit, CD4, TCRγ , and TCRδ gene expression (120–122). It is most
obviously involved in proliferative phases such as β-selection (123). Recently,
through conditional inactivation at different stages of T cell development, the crit-
ical role for c-Myb has been confirmed at β-selection (124), in part associated
with reduced rearrangement at the TCR-β locus. Furthermore, c-Myb is important
for survival of DP thymocytes and specifically for the development of CD4 SP
thymocytes (124).
Hit-and-Run Specification Factors: PU.1
The last group of essential T cell regulators is different in that it both supports
and constrains T-lineage development. This group is represented by PU.1, a di-
vergent Ets subfamily member, which is expressed only in the earliest stages of
T cell development, along with other stem-cell legacy genes such as GATA-2 and
SCL/Tal-1 (125–127; T. Taghon, R. Pant & E.V. Rothenberg, unpublished data).
A close relative of PU.1, Spi-B, is also expressed in DN thymocytes and then shut
off at β-selection (125, 128). PU.1 is not expressed in mature T cells, and instead
plays continuing roles in macrophage, granulocyte, and B cell development (129,
130). It is possible that the role of PU.1 for T cell precursors is mainly to provide
a general proliferative function prior to specification; there is evidence that PU.1
acts this way in the erythroid lineage, where it also has a hit-and-run role (131). In
early B cell precursors, PU.1 is important for IL-7Rα expression (132), and, con-
ceivably, some of these cells are uncommitted precursors of T cells as well. PU.1
function is most important for the earliest precursors of the fetal cohorts of T cells
(133). If its role is basically proliferative in these cells, it is curious that these are
pre-T cell populations in which TCF/LEF function seems to be less critical (112).
Conceivably, there could be a fetal-specific proliferative mechanism dependent on
PU.1 that is replaced in postnatal lymphopoiesis by one dependent on Wnt/TCF-1.
While PU.1 gene disruption destroys fetal T cell development (126, 133), forced
maintenance of PU.1 expression in precursors also blocks T cell development at
early stages (134). Thus, PU.1 support of fetal T cell development is dose depen-
dent, and also, obligatorily, a hit-and-run role. Besides supporting the proliferation
of multilineage lymphoid precursors, PU.1 and Spi-B may in fact maintain the non-
T-cell developmental options of these precursors, prior to T-lineage commitment
(134, 135). The linkage between acquisition of T cell characteristics and closure
of alternative options is discussed in detail below.
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
616 ROTHENBERG  TAGHON
OTHER TRANSCRIPTION FACTORS WITH
SPECIALIZED ROLES IN T CELL DEVELOPMENT
The factors already listed do not fully account for all the lineage-specific aspects
of T cell development. There are additional regulators that have potent impacts on
a few selective aspects of T cell development in the thymus, or which are less well
characterized in this context than those we have already introduced. Two widely
used classes of transcription factors, Ets family factors and HOX cluster factors, are
used in developing T cells, although the coexpression of multiple family members
with overlapping functions makes it harder to use genetics to distinguish all the
roles of individual genes. Another group consists of the T-box factors T-bet and
eomesodermin and their collaborator Hlx. These are factors that are well known in
peripheral T cell differentiation in response to antigen, but which may also play a
role in the intrathymic differentiation of particular T and NK cell lineages. There
are also a number of dedicated transcriptional repressors and nuclear localization-
directing factors whose roles will eventually need to be explained.
Ets Family Transcription Factors: Continuing Roles,
Multiple Players
Transcription factors of the Ets family are strongly implicated in early T cell gene
regulation. Binding sites for these factors are found in the regulatory regions of
multiple lymphocyte differentiation genes, often linked to Runx sites and/or over-
lapping with Ikaros sites (92, 94, 95, 136). In the T cell lineage, Ets family function
is guaranteed by redundancy. Ets-1, Ets-2, Fli, Tel, Elf, and GABPα are among
the members of this family that are expressed throughout most of T cell devel-
opment, with Erg and members of the divergent PU.1/Spi subfamily expressed
for more limited periods (125). The overlapping expression patterns of these fac-
tors and their redundant DNA-binding specificities make it easy to underestimate
their regulatory importance for T cell development if one only considers results
of single-gene mutants (137). The effects of Ets-1 knockouts are sharper in NK
cells, which do not express such high levels of other Ets family members (138).
However, recent data indicate that GABPα may play a specific role in IL-7Rα
gene expression in T-lineage cells (139).
HOX Genes
Homeodomain-containing HOX genes are crucial mediators of patterning of the
anterior/posterior axis during embryonic development, and increasing evidence
points to their role as mediators of hematopoiesis. Primarily, genes of the HOX-A
cluster seem to be expressed in hematopoietic cells (140). There is some evidence
for a developmental expression pattern colinear with the order of genes in the
cluster, as during embryogenesis, in some hematopoietic lineages and also dur-
ing T cell development (141). Little functional evidence is available from HOX
knockout studies yet due to their lethality, and T-lineage conditional inactivation
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studies are lacking. HOX-A9, however, has been shown to be crucial for T cell
development, as well as for certain other hematopoietic lineages. Mice deficient
for this gene display a severe reduction in DN2 and DN3 thymocytes, possibly due
to a lack of IL-7R expression (142).
T-box Factors T-bet (Tbx21) and Eomesodermin,
and their Collaborators
Functional maturation of multiple T cell subsets depends upon the Tbx-family
factors, T-bet (Tbx21, Tbt-1) and Eomesodermin, which promote the ability to
express IFN-γ , and may also activate granzyme B and perforin (55, 143–147). T-
bet is expressed alone in activated CD4 conventional Th1 and NKT cells, whereas
Eomesodermin contributes a partially redundant function in CD8 conventional
T cells and in NK cells. In mature conventional TCRαβ CD4 cells, T-bet represents
a critical node in a bistable regulatory network, where it promotes the establishment
of Th1-type function in opposition to GATA-3 (reviewed in 44, 45). Not only is
T-bet essential for postthymic differentiation of Th1 cells, but it also is specifically
required for intrathymic generation of the whole NKT lineage of T cells (147).
To activate differentiation to a Th1 effector fate, T-bet induces expression of
another factor, the divergent homeodomain transcription factor Hlx, which then
collaborates with it to turn on IFNγ (148–150). Recent data suggest that T-bet can
also activate one of the promoters of Runx1 (147), which could provide an indirect
mechanism for it to inhibit GATA-3 expression in some contexts, as described
above (100). In T cell subsets other than conventional TCRαβ cells, however,
T-bet and GATA-3 appear to be mutually compatible in their contributions to
function, as for example in TCRγ δ cells, NK cells, and NKT cells (55, 147). (For
excellent discussion of the other factors used for NK and NKT cell development,
see 147, 151).
Although T-bet and eomesodermin are not T-lineage specific and are not yet
known to play any early role in T cell precursor specification, there is early, reg-
ulated expression of T-bet in DN thymocytes (E.-S. David & E.V. Rothenberg,
unpublished data). Direct perturbation experiments will be needed to determine
whether precocious induction of these genes could play a role in the T/NK or the
TCRαβ/TCRγ δ lineage choices.
TOX: A New HMG Box Factor
Both β-selection and positive selection are induced by TCR-mediated signaling,
and a new transcription factor has been identified as a target of this signaling that
plays a role in both processes. TOX is a novel member of the family of HMG box
containing transcription factors that also comprises other important mediators of
T cell development, such as TCF-1 and LEF-1 (152). TOX is specifically upreg-
ulated following pre-TCR signaling and positive selection, but, strikingly, does
not seem to be involved in TCR-mediated activation of mature, peripheral T cells.
Transgenic mice that express TOX under the control of the Lck promoter show
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an increase in both ISP (post β-selection) and SP (post positive selection) CD8+
thymocytes. TOX induction during positive selection is calcineurin dependent and
results in Runx3 upregulation, which in turn downregulates CD4 (153). This cas-
cade can be counteracted by strong or sustained TCR signaling, a process that
involves upregulation of GATA-3. Thus, the strength of TCR-mediated signaling
at positive selection seems to change GATA-3 versus TOX ratios to result in CD4
versus CD8 lineage development (153), though this model awaits confirmation by
knockout studies.
Essential Repressors: Gfi-1, N-CoR1, and δEF1
Mutations in several genes coding for dedicated transcriptional repressors sug-
gest that repression may be an essential aspect of T cell specification, at least
at particular stages. The repressors analyzed to date are not T-lineage-specific in
their expression and their roles in T cell development have mostly emerged as
incidental features of a more global phenotype. But there is compelling evidence
that losses of function of the repressors Gfi-1, N-CoR1, or δEF1 (ZEB, AREB6,
Zfh, TCF-8) can each severely distort T cell development at specific stages. All
three are normally expressed throughout most of intrathymic development, but the
target genes that they must repress are not defined yet. While one can speculate
that genes such as PU.1 should be important targets of stage-specific repression,
very little is clear yet about the way these factors actually work to promote T cell
development. The stages affected by loss of function of these three repressors are
apparently different, although they have not been fully characterized to date.
Either a partial or a complete loss of function of the zinc finger-homeodomain
repressor δEF1 causes a severe loss of thymic cellularity, with a particularly strong
decrease in the earliest c-kit+ intrathymic populations and the DP cells (154). Some
recovery occurs in later stages. The severity of this phenotype appears paradoxical,
because δEF1 (ZEB) is capable of competing with E proteins to interfere with acti-
vation at E-box sites, and loss of δEF1 should favor activity of E proteins in T cell
gene expression. There is even evidence that this repressor could downregulate
GATA-3 expression itself (68). However, recall that both GATA-3 and E proteins
can only promote T cell development when they themselves are under tight regu-
lation (see above). A tonic level of repression of critical genes by δEF1 may also
be important to maintain expression within tolerable limits (as for GATA-3) or to
enforce specificity by requiring concerted action by positively regulating factors
(155). δEF1 mutants also show derepressed integrin α4 expression, which could
affect migration among appropriate zones of the thymus (154).
The nuclear receptor corepressor N-CoR1 has a strikingly important role in
enabling thymocytes to develop through β-selection. In an N-CoR1 knockout,
thymocytes are blocked almost completely at the DN to DP transition (156). Un-
fortunately, no further characterization is available. The DN to DP transition is a
time of very rapid proliferation and rapid shifts in the requirements for E box pro-
teins, their Id antagonists, TCF, and c-Myb, as described above. Availability of this
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general-purpose repressive cofactor may be essential to mediate these regulatory
shifts. Alternatively, the lack of N-CoR may have resulted in a failure to generate
a pre-TCR in the first place, e.g., by interfering with TCR gene rearrangement.
The mutants of Gfi-1 have a subtler phenotype that affects particular stages of
development both before and after β-selection. Gfi-1 is a repressor with 6 zinc
fingers and a SNAG repression domain, and it is needed for normal development
of neutrophils but not of granulocyte-macrophage precursors or of erythroid cells.
In Gfi-1−/− mutants, B cell development and T cell development are both partially
inhibited, with clear bottlenecks in the progression of DN thymocytes to normal
DN2 and DN3 states, depressed CD4 SP-cell production, and enhanced CD8-cell
production (157, 158). These perturbations are consistent with the developmental
pattern of Gfi-1 expression in the thymus, which is turned on in the DN2 stage and
persists through the DP stage (159). Gfi-1 may be important to repress the bHLH
antagonist Id proteins at the correct stages, since Id2 and Id1 are aberrantly highly
expressed in the Gfi-1−/− thymus (158). However, this could also be an indirect
effect of abnormal precursor utilization in the thymus, since the DN1 subset in
these mutants appears abnormal (158), lacking the c-kit+ IL-7Rlow cells that are
the most potent T cell precursors in a normal thymus (108).
Some ambiguity attends the role of Gfi-1, in part because it has a close rel-
ative that is also expressed in the thymus, Gfi-1B. This repressor is similar in
overall structure to Gfi-1, but diverges in sequence, and its effects are either re-
dundant or antagonistic to those of Gfi-1 depending on the developmental context.
Gfi-1B is expressed more narrowly in hematopoiesis, preferentially in erythroid
lineage cells, where it is required (159–161). In thymocytes, Gfi-1B is reportedly
expressed only in a sharp spike in the DN3 stage, where it may play a role in
β-selection (159). It is not clear which factor, Gfi-1 or Gfi-1B, is more important
during β-selection in vivo. However, there is evidence from a peripheral T cell
system that Gfi-1 has another, distinctive function that could make it valuable in
the T-lineage specification process. In mature peripheral T cells undergoing stimu-
lation under Th2 conditions, Gfi-1 is induced in parallel with GATA-3. Then Gfi-1
permits efficient cell proliferation to proceed, counteracting the cytostatic effects
of GATA-3 while preserving differentiative functions of GATA-3 (162). As noted
above, prethymic T cell precursors can only tolerate low levels of GATA-3 (47),
even though they cannot develop further without it. Thus the Gfi-1 expression
could be important to provide a protective function for DN2/DN3 thymocytes, en-
abling them to couple strong proliferation with their differentiation in response to
GATA-3.
Chromatin Modifier SATB1
T cell development appears to require not only a multitude of repressors but also
at least one factor that associates specific DNA sequences with the nuclear ma-
trix, the Special AT-rich Binding protein SATB1. SATB1 is a two-Cut domain-
Homeodomain protein that is expressed preferentially in thymocytes, and T cell
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development is severely deranged, though not completely blocked, in SATB1 mu-
tants (163). The activation properties of SATB1−/− peripheral T cells are also
defective, resembling those of DP thymocytes or cells just undergoing positive
selection, suggesting that the loss of SATB1 allows them to emigrate to the periph-
ery without actually having matured. Although it does not act like a conventional
sequence-specific transcription factor, SATB1 appears to be needed to choreograph
a range of distinct gene regulation transitions during development. This factor is
primarily known as a negative regulator, as it is essential for the correct timing of
repression of the CD25 (IL-2Rα) and CD127 (IL-7Rα) genes in DP thymocytes.
However, it is also needed for correct positive as well as negative regulation of the
CD2, CD5, GABPα, CD8α, and c-Myc genes (41, 163, 164).
It now appears that the role of SATB1 is to propagate a particular chromatin con-
figuration over a broad domain that can extend tens of kilobases from the SATB1
binding site itself (164, 165). The nuclear matrix interaction capability of SATB1
may play a physical part in this role, as recent evidence shows that a number of lym-
phocyte gene expression choices involve compartmentalizing nonexpressed alleles
to the nuclear periphery (reviewed in 166). This makes SATB1 a very important
effector of regulatory information-processing “decisions.” It is very provocative
that developing thymocytes should require a dedicated, cell type–specific factor
of this type. However, the very permissive sequence specificity of SATB1 and the
situation-dependent way in which it engages different subsets of its target genes
make it in some ways more akin to a general chromatin remodeling factor than to
a sequence-specific transcription factor. These characteristics strongly imply that
interactions with other, highly specific factor complexes are required to deploy
SATB1 to the correct sites and perhaps to select its correct functions.
PATTERNS OF COMBINATORIAL TRANSCRIPTION
FACTOR ACTION IN T VERSUS B CELL DEVELOPMENT
We have already considered the activities of individual factors, “longitudinally”
through T cell development. However, none of them work solo at any T cell
developmental stage or choice point. The same factors used in specification are also
used later in T cell differentiation, in combinations that shift from stage to stage,
giving each choice point and checkpoint of T cell development a distinct regulatory
signature. Each of these transitions can only be dissected mechanistically with
reference to the combination of factors that acts at that point. To put the complexity
of the T cell developmental process in perspective, it is helpful to compare it with
the regulatory cascade that is now thought to specify the B lymphocyte lineage.
A Comparative Model: The B Cell Gene Regulatory Network
The molecular genetics of B cell development have been elucidated dramatically
since the late 1990s, as summarized in Figure 5 (reviewed in 7, 167–169). B cell
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Figure 5 Gene regulatory network for B cell specification and commitment. This fig-
ure is based on the body of work cited in the text, in which B cell development depends
on the combined action of three factors, E2A, EBF, and Pax-5. The figure highlights
the network topology that is supported thus far by genetic epistasis experiments, as
well as the distinctive roles of E2A, EBF, and Pax-5 in the positive and negative gene
expression required for B-lineage commitment. Some evidence exists to link PU.1 ac-
tion with the initiation of EBF expression, possibly involving the expression of IL-7Rα
for optimized growth under permissive signaling conditions.
development from pluripotent hematopoietic precursors is guided by the three
transcription factors E2A, EBF (Early B cell factor, a.k.a. Olf-1), and Pax5. These
factors act in a relatively simple gene regulatory cascade in the initial stages of B
cell specification. The precursor in which the specification process will unfold is
normally rendered competent by its expression of PU.1 and Ikaros, without which
B cell development does not begin (108, 132, 170). Increasing levels of E2A in
such a precursor turn on EBF expression (171), possibly in collaboration with
PU.1. In turn, EBF then collaborates with E2A, and/or with other bHLH factors
of the same class if necessary (HEB, E2-2), to turn on expression of additional
downstream genes and of Pax5 (169, 172, 173). Pax5 is not needed for the initiation
of B cell gene expression, but it activates definitive B cell genes and locks down the
committed B cell state by foreclosing other developmental options. It can directly
block T cell specification, in part through downregulation of Notch (174), and it
can interfere with correct regulation of myeloid target genes by PU.1 to disfavor
additional options.
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The polarity of this network is shown by the effects of knockouts and by the
epistatic rescue of PU.1 or E2A mutants when EBF expression is turned on artifi-
cially (169, 173). Just as loss of expression of any of the B cell regulators interferes
with B cell development, gain of expression of EBF or Pax5 enhances B cell devel-
opment (172, 174, 175). Notably, these increases in B cell development in response
to either EBF or Pax5 are primarily at the expense of T cell development. In gen-
eral, the B cell–specific trio of E2A, EBF, and Pax5 are expressed and control
gene expression throughout precursor differentiation to maturity. E2A and Pax5
then continue to be required in mature peripheral B cells, until Pax5 is shut off
during the antigen-dependent terminal differentiation of B cells into plasma cells.
The continued function of the B cell transcriptional cascade reflects the fact that
these factors regulate not only the expression of genes used in particular stages of
B cell development—surrogate light chains, RAG genes, and Activation Induced
Deaminase (AID) at different stages—but also the transcriptional accessibility of
the immunoglobulin genes in chromatin (176–179). These activities make the B
cell–specification factors important for somatic hypermutation and heavy chain
class-switching in mature, activated B cells as well as for initial VDJ rearrange-
ment in their early precursors.
T Lineage Versus B Lineage: An Overview
The paradigm developed for B cell development includes several features in com-
mon with T cell development. These are (a) the absolute requirements for bHLH
factors (E2A, and/or HEB, E2-2) and for Ikaros family factors (Ikaros, Aiolos,
Helios), and (b) the derivation of both B and T cells (at least in fetal life) from
PU.1-expressing progenitors. Genes active in B cell precursors also share with
those active in T cell precursors the importance of combinations of Runx and
Ets transcription factor binding sites (95). Together, these observations impli-
cate bHLH, Ikaros, PU.1, and Runx expression in shared aspects of T and B cell
development. However, the two pathways differ markedly in the other specific
factors that become activated in these precursors: EBF and Pax5 as opposed to
GATA-3, TCF-1, and Notch/RBPSuh. More provocatively, they may differ also
in the regulatory relationships among these factors and the developmental mech-
anisms used for T and B cell specification.
In comparison with B cell development, several process components appear to
be lacking during T-lineage specification. There is no factor expressed selectively
in T cell precursors that has an unequivocal positive role, an equivalent of EBF
or Pax5 in B cell development. None of the T cell transcription factors has yet
been able, when overexpressed, to drive the development of multipotent progeni-
tors instructively into the T cell pathway, except the activation of Notch/RBPSuh
activity, which is not T-lineage specific (180). There is also no clear identification
yet of the factor(s) playing a lineage-specific commitment role through direct or
indirect repression, a role that is played in B cell development by Pax5.
The T-lineage program itself includes multiple discontinuities and branch points,
as shown in Figure 1, and the developmental choices that remain open each require
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divergent actions of different transcription factor coalitions. Thus the transcription
factors used in specification are repeatedly brought back into play, but with shifting
patterns of cooperation and antagonism as maturation proceeds.
A Succession of Different Regulatory Coalitions
at Different Stages of T Cell Development
Figure 6 broadly summarizes major phases of action of key T cell transcription fac-
tors. The factors that work positively to establish T-lineage identity as distinct from
other hematopoietic cell types, from the earliest stages, include Notch/RBPSuh,
GATA-3, TCF/LEF factors, and E proteins such as E2A and HEB. As we discuss
below in detail, levels of Notch, E protein, and GATA-3 activity as opposed to Id
and PU.1 activity seem to be crucial to decide whether precursors will choose T as
opposed to B, NK, or dendritic cell (DC) lineage fates. These factors collaborate
with a broader group that establish the precursor subset(s) from which T-lineage
specification can occur: c-Myb, Runx factors, Ikaros, and PU.1 and/or other Ets
factors.
Figure 6 Complex regulatory requirements of T cell development at multiple
T-lineage checkpoints. The figure summarizes genetic analyses showing functional
dependence of T cell development on shifting combinations of multiple specific tran-
scription factors, loss of any of which blocks at the indicated stages. Events occurring
in the periphery are not included. For details, see text. Black, extreme dependence
(knockout has severe effect). Gray, moderate or uncertain dependence. White, no de-
pendence, possible antagonist effect. Broken lines indicate stages when factors are
likely expressed but genetic evidence for functional dependence is lacking.
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The pausing of T cell precursors at the DN3 stage, and the enforcement of
the β-selection checkpoint, involve both Ikaros family and E proteins. The cells
express a particularly high level of active Notch and its target genes. In agreement
with the high E protein activity, this is the period when the most active TCR gene
rearrangement is unleashed by the highest RAG gene expression, and when the
highest levels of pTα are expressed, favoring TCRαβ precursor differentiation.
Meanwhile, PU.1 and other non-T regulators are shut off at this point.
For TCRαβ precursors, β-selection depends on a particularly broad coalition
of transcriptional regulators. One set of factors is activated simply by the pre-TCR
signal itself: This set includes immediate early Zn finger transcription factors
of the Egr family, NF-AT, and NF-κB (181–183). However, this is not simply
an activation event; it is a mini-differentiation cascade that recalls virtually all
the T cell identity-determining factors to participate in some kind of genetically
required role.
To initiate β-selection, Notch signaling seems to be essential (15), though the
Notch-activated target gene Hes-1 declines in expression throughout the DN to DP
transition, suggesting that this signaling is transient. Meanwhile, E protein roles
shift rapidly from the E protein–mediated DN3 arrest, through an Id3-dependent
proliferative phase, then back to a phase when a particular E protein (HEB) becomes
essential, as the cells approach the DP postmitotic state (74, 184). β-selection
causes GATA-3 levels to rise, and GATA-3 activity becomes rate-limiting at least
for the early phases of the DN to DP transition (32, 35, 36). At the same time, c-Myb
becomes a critical proliferative driver (118, 123), Runx1 continues to be important
for full population expansion (86), and TCF-1 or its relative LEF-1 becomes indis-
pensable, especially in the later phases of the β-selection response (111, 113, 114).
However, this is not a regulatory free-for-all. β-selection terminates the expression
of the last PU.1/Spi family member, Spi-B, and the expression of other specific
Ets and bHLH transcription factor variants that added to the regulatory complex-
ity of the precursor stages (125; M.K. Anderson & E.V. Rothenberg, unpublished
results). Conceivably, the repressors such as Gfi-1 and N-CoR that are required at
this stage play a role in execution of these silencing events.
Afterβ-selection, DP cells have a short default lifetime that can only be extended
by successful positive selection to the CD4 or CD8 lineage. TCF-1 and c-Myb
appear to act as viability factors (114, 124). At this point, regulatory requirements
for further differentiation appear much simplified. TCR-activated signaling factors
such as NF-AT family members, AP-1 and NF-κB, are undoubtedly involved in
the transient positive selection signal. There is evidence that strong, sustained
signaling in positive selection directly activates the GATA-3 gene (35), whereas
transient signaling selectively activates Runx3 expression (99). GATA-3 activity
supports the differentiation of cells that are selected to the CD4-cell fate (35, 36).
Conversely, when Runx3 is activated together with Ikaros it directs or sustains cells
that proceed to the CD8-cell fate (84–86, 98, 99a, 103), with a possible contribution
from Notch mediators as well (185).
In peripheral CD4 cells, GATA-3 and Runx again appear to be in opposition, but
now they are associated with different collaborators than in the CD4/CD8 lineage
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choice. Recent evidence suggests that for Th2 differentiation, GATA-3 once again
works in parallel with some form of Notch signaling, as in the earliest stages of
thymocyte specification (27), but in apparent contrast to the CD4/CD8 choice in
positive selection. Meanwhile, in Th1 differentiation, Runx factors are presumably
activated by T-bet (147) and act in collaboration with T-bet and Hlx.
Another important developmental branch point that is only starting to be ex-
plained is in the DN2 and DN3 stages, when TCRγ δ cells diverge from the TCRαβ
lineage. These two major subdivisions of T cells are biologically distinct through-
out most vertebrates (186–188) and differ in a significant number of respects, only
the first of which is the ability of TCRγ δ cells to mature successfully without
undergoing the regulatory upheaval of β-selection or the proliferative burst that
accompanies it (189–193). TCRγ δ cells differ from TCRαβ cells in their devel-
opmental responses to levels of E protein activity and to increases or decreases in
Notch signaling levels (12, 13, 72, 194–198). Both Notch signaling and E protein
activity are essential throughout the DN period for all T cell precursors, but the
lower levels that seem to be acceptable for TCRγ δ cell development could form
a continuum with the levels that are permissive only for NK-cell development.
The window of opportunity for the NK- and DC-lineage options stays open long
enough to raise a question as to whether it overlaps with the branch point between
TCRαβ and TCRγ δ pathways of T cell development (196, 199). Thus it is pos-
sible that the choice between TCRαβ and TCRγ δ T cell fates is mechanistically
intertwined with the choice between T, NK, and DC fates.
Several other T-lineage choice points remain poorly explained. NKT cells de-
pend on a constellation of regulators more typical of NK cells than of T cells (147,
200–203), and it is intriguing but obscure how this alternative program is accessed
from precursors that presumably diverge only after β-selection (204). Treg cells,
active guardians of tolerance, also appear to emerge in the thymus and begin to
express the transcription factor Foxp3, but the intrathymic stimuli that direct this
program likewise remain to be defined (205).
T CELL LINEAGE SPECIFICATION AND COMMITMENT
Initial T cell specification and its relationship to commitment define an important
frontier. This is the process that first demands the great regulatory complexity of
T cell development that we have just reviewed, invoking the aid of a large fraction
of the regulators that will be used in all subsequent steps of T cell development
combined. Also, the regulatory properties of the earliest T cell precursors often
appear close to those of leukemic cells, suggesting that enforcement of the correct
regulatory relationships in this process may be critical to prevent malignant trans-
formation. The last section of this review is therefore focused on what is known
about the molecular mechanisms that initially establish T-lineage identity.
To date, it has not yet been possible to demonstrate a straightforward regulatory
cascade, with clear polarity and epistasis relationships, for the transcription fac-
tors involved in T cell development. There are several reasons for this, not merely
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technical but reflecting significant aspects of the T cell specification mechanism.
First, the T cell development program can have multiple, diverse points of entry,
in regulatory terms. Second, there is a massive overlap between the regulatory
requirements of T cell specification and the hematopoietic stem-cell program.
Third, there is the strikingly prolonged and flexible specification and commitment
process itself. Finally, as a result, early T-lineage differentiation is intensely depen-
dent on environmental conditions to maintain not only viability but also T-lineage
identity.
A Pathway with Multiple Entry Points
The first important step for T cell development to occur is the migration of a mul-
tipotent progenitor toward the thymus. Thymic immigration places the precursors
in an environment rich with the Delta-like Notch ligands that are critical for T cell
development (25, 26), and indeed this entry triggers a burst of Notch activation
(206). Another feature that may be specific to the thymic microenvironment is
high oxygen tension, which may be essential for T cell development (34, 207).
Finally, the thymus is a rich source of ligands for the two growth factor receptors
expressed on early T cell precursors, c-kit and IL-7, as well as Wnt factors that
activate TCF-1/LEF-1 transcription factors. These distinctive microenvironmental
features are important to initiate and sustain the specification process.
Recent evidence shows that the most likely cell to migrate from the bone marrow
to the thymus under normal conditions has a Lin− Sca-1+c-Kit+ (LSK) pheno-
type (208) (Figure 7). Cells with this phenotype, also found in the bone marrow,
include self-renewing HSCs and multipotential progenitors. The thymus can thus
initiate T cell development in cells that have diverse developmental alternatives.
Moreover, this is not the only class of cells that is poised to respond to the thymic
microenvironment.
There is now evidence for at least four different kinds of murine prethymic cells
that can give rise to T cells when introduced into an appropriate environment, as
shown in Figure 7 (209–213). Virtually all uncommitted T cell precursors are ca-
pable of differentiating into NK cells as well (16, 214), but they are distinguished
in terms of their retention of B and/or myeloid potential. One is the Common
Lymphoid Progenitor (CLP), a Sca-1lo c-kitlo IL-7Rα+ Lin− bone marrow cell
type. CLPs are also efficient B cell precursors but lack myeloid potential (215).
A variant CLP (CLP-2) is also found in the bone marrow, with a c-kitlo B220+
phenotype and the capacity to generate both B and T cells (216). A different kind of
precursor is an Early T cell Progenitor (ETP), first characterized among the highly
immature cells in the thymus and thus part of the DN1 compartment. The ETP is
a less efficient B cell precursor than the CLP, in agreement with its intrathymic
appearance, but it is a better myeloid precursor (108). The ETP is Sca-1+ c-kit+
IL-7Rα− Lin− and differs from the CLP in that its generation and developmental
capacities do not depend on Ikaros (108). Cells resembling ETP can be found
in the bone marrow, where they represent a T lineage–biased, efficient source of
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Figure 7 Distinct precursor cell types with the shared competence to generate T cells
in the thymus. The figure summarizes the studies reviewed in the text, where a variety of
different adult cell types with different combinations of other developmental potentials are all
capable of responding to the thymic microenvironment and differentiating into T cells. LSK:
the Lin− Sca-1+ c-Kit+ bone marrow cell fraction, highly pluripotent and recently shown
to be the most prevalent source of thymus immigrating cells in normal animals. ETP: first
defined as a partially restricted intrathymic subset of Early T cell Progenitors within the DN1
population, which appears to represent an early derivative of the immigrants after arrival in
the thymus. ELP: the Early Lymphoid Precursor, a population with excellent T- and B-lineage
potential that retains some myeloid potential but with much reduced nonlymphoid activity
as compared with LSK cells. CLP and CLP-2: two distinct types of Common Lymphoid
Progenitors, with strong B-lineage potential as well as T potential but little or no myeloid
potential.
thymus-populating cells (217). Yet another cell type that may represent the pre-
cursor of both the ETP and the CLP, called the Early Lymphoid Precursor (ELP),
has been described in the adult bone marrow and identified by its expression of
a RAG1-GFP knock-in gene. The ELP can generate T, B, NK, and myeloid cells
with different efficiencies (218) (Figure 7).
A somewhat different hierarchy of shared developmental potentials is found
in prethymic cells in the fetus (not shown). In the fetal liver, the Sca-1+ c-kit+
Lin− cells that give rise to T cell precursors generally exhibit substantial myeloid
potential, and myeloid and T potentials are maintained together even when B cell
potential is lost. The fetal precursors also differ in other respects from the prethymic
cells in the adult (219–222).
While a simpler, more linear scheme for stepwise commitment might be more
appealing, the variable order in which B versus myeloid potentials are lost among
precursors appears to be a genuine feature of the cells competent to undertake
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the T cell developmental pathway. Even within the adult thymus, phenotypically
diverse T-lineage precursors can be found that give rise to T cells with different
kinetics and with different combinations of alternative B, NK, and myeloid devel-
opmental capabilities (223). The predictable, robust differences in developmental
potential among these precursors imply that they express different transcription
factor combinations that situate them in distinct regulatory states. Thus, the gene
regulatory network that operates in T-lineage specification must be capable of fun-
neling this whole range of different input regulatory states into a common T cell
developmental progression.
Similarities Between Stem-Cell and T Cell
Regulatory Programs
One way to force diverse precursors into a common program would be to express
dominant transcriptional regulators that actively repress alternative, pluripotent
states. However, this is not the way that T-lineage specification seems to proceed.
Instead, there is a striking overlap between the factors required for the T-lineage
specification process and factors known to be used, even required, in multipotent
hematopoietic stem cells. Ikaros, PU.1, Runx1, and c-Myb are required not only
for T cell specification; they are also important for stem-cell specification, mainte-
nance, or self-renewal (106, 119, 224, 225). Notch pathway and Wnt/TCF signaling
may also be used to promote stem-cell self-renewal (116, 226). Even GATA-3 is
structurally very similar to the essential stem-cell factor GATA-2. These overlap-
ping regulatory requirements obviously pose technical problems for gene knockout
strategies to investigate the modes of action of these factors in early stages of T cell
specification. More interestingly, though, they bring into sharp focus a global reg-
ulatory similarity between the stem-cell state and the state of a T cell precursor
even after specification and commitment (Figure 8).
The number of regulatory changes needed to bridge the gap from stem cell/
multipotent progenitor to DN2 thymocyte could be small. Among the obvious
candidates, lymphoid precursors might diverge from multipotent progenitors by
altering the relative activities of different bHLH heterodimers and their interac-
tion partners (e.g., via downregulation of Id1, SCL/Tal-1, and Lmo1/2); but the
essential positive bHLH factors, E2A and HEB, are expressed in stem cells as
well. One clear difference is that GATA-3 is induced, whereas GATA-2 is down-
regulated. Furthermore, GATA-3 might be an important mediator in the migration
of LSK cells to the thymus, since GATA-3 deficiency results in the absence of
even the earliest, DN1-stage thymocytes (32). Thus, if not important for migra-
tion, it at least is required for the survival of the earliest thymocytes. However,
if GATA-3 can serve any of the same functions as GATA-2, then the continuities
between early stage T cells and stem cells are even more impressive (Figure 8).
It should not be surprising, therefore, that the T cell pathway is also accessible
from a number of different, separable pathways from the multipotent LSK cell
(Figure 7).
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Figure 8 Similarities between T cell and stem-cell regulatory states. In compari-
son with hematopoietic stem cells (center cell, left), committed T cell precursors also
remain “pluripotent” (center cell, right) insofar as they still face a succession of devel-
opmental choices that determine divergent functions, gene expression programs, and
physiological setpoints within the T lineage. Transcription factors that are genetically
shown to be important for development or maintenance of definitive HSC (bottom left)
define a very similar set to those that are important for T-lineage specification (bottom
right).
Timing of Specification and Lineage Choice Events
Specification involves the activation of a first tier of T-lineage genes, and this must
be one of the key roles of the combinations of factors involved in this process. The
genes that need to be turned on in order to qualify a precursor cell for success in
early T-lineage development include those encoding RAG-1 and RAG-2 recom-
binase components, the CD3γ and ε chains of the TCR and pre-TCR complexes,
lineage-specific signaling molecules such as LAT and Lck, and for future TCRαβ
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cells, the surrogate α chain pTα. Also required for TCR gene rearrangement is
the transcription factor-mediated opening of the respective loci in chromatin, and
for survival through the initial stages IL-7Rα and γ c expression are needed. The
T-lineage-required transcription factors themselves must also be turned on, at the
correct times and levels, to regulate these and other, as yet unknown, target genes.
Certain cis-regulatory elements associated with TCR (38, 91, 93, 94, 227), pTα
(65, 66, 228), Lck (229, 230), and RAG (39, 97, 231) genes appear to include targets
for RBPSuh, c-Myb, bHLH E proteins, Runx1, GATA-3, and/or TCF/LEF factors.
However, remarkably few of the regulatory systems that control early T cell genes
have been characterized in sufficient detail to establish factor-specific causality.
Another regulatory feature needed for optimal T cell development is extensive
proliferation. For the proliferation that occurs in the DN2 stage, E proteins must
collaborate with IL-7Rα signaling to maintain viability (67), while TCF-1, c-Myb,
and the Notch-activated transcriptional repressor Hes-1 are vital to sustain clonal
expansion (112, 118, 232). “Normal” development of individual precursors can
involve ∼105-fold expansion, with ∼103-fold expansion prior to β-selection (233).
Thus, another requirement of the specification process may be a surprising one: to
delay terminal differentiation, while proliferation continues.
Indeed, a remarkable feature about T-lineage commitment is how late it can
occur, even relative to specification. Figure 1 shows the approximate windows of
opportunity for development into B, myeloid, NK, and dendritic cells as alterna-
tives to T cell development. The full foreclosure of all of these alternatives does
not appear to occur until the DN3 (c-kit− CD44− CD25+) stage (reviewed in 211;
16, 234). This can take 7–10 rounds of proliferation in the fetal thymus (233) and
nearly two weeks in the adult thymus (235). Thus, DN3-stage commitment is late
in terms of the onset of T-lineage gene expression, which is clearly under way
by the DN2 stage; it is late relative to the beginning to TCR gene rearrangement;
and in the adult thymus, it is late in terms of the absolute number of days and cell
cycles elapsed since the entry of the cells into the thymus (reviewed by 212, 235,
236).
Whereas other potentials are eliminated earlier, both postnatal and fetal thymo-
cytes remain capable of differentiating into dendritic cells and/or NK cells instead
of T cells throughout the DN1 and DN2 stages (63, 234, 237–240) (Figure 1). In
the fetal thymus, these subsets are capable of macrophage differentiation as well
(241). B cell potential is lost much earlier within the thymus and is undetectable
among most of the subsets within the DN1 population (212, 223), presumably as
a result of direct inhibition via Notch/Delta signaling in the thymic microenvi-
ronment (206). Both the NK and the dendritic cell fates, though less favored by
Notch/Delta signaling than the T cell fate, are substantially more tolerant of this
than the B cell fate (25, 197, 242). These alternatives can be elicited simply by
incubation of the DN1 or DN2 thymocytes under appropriate growth conditions,
i.e., by moving them into an irradiated host or into in vitro conditions that dif-
fer from those presented by the thymic microenvironment. As the DN1 and DN2
stages include the highest frequencies of proliferating cells in the thymus except
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for those immediately responding to β-selection, this implies that the uncommitted
state is actively maintained.
At the individual cell level, even turning on T cell genes does not guarantee
commitment. RAG-negative NK cells can develop from RAG1-expressing precur-
sors (218). Myeloid-like dendritic cells can develop from cells that have previously
turned on pTα, the component of the pre-TCR, or active RAG recombinase, as
shown by the presence of limited lymphoid-type gene rearrangements in their DNA
(243). The likelihood of trans-specification during the DN1 and DN2 stages can
also be boosted dramatically by delivering artificial stimulation to the immature
thymocytes. Signals delivered through an ectopically expressed IL-2 receptor or
GM-CSF receptor complex can convert most DN2 cells quickly to myeloid cells,
even if they have already undergone significant TCR gene rearrangement (244,
245). Once the cells are committed, in the DN3 stage, this response is no longer
seen. The exceptional plasticity of DN1 and DN2 cells shows that the early stages
of the T-lineage program are compatible with expression of regulatory factors that
can execute alternative developmental programs.
Coexpression of Potentially Antagonistic
Transcription Factors During Specification
Many of the factors required for T cell specification have spectra of activity that
can include inhibitory as well as stimulatory effects on T cell development. The
extended window of opportunity for developmental alternatives could be the result
of potentially antagonistic activities among these delicately balanced factors (211)
(Figure 9).
From the prethymic stages through the DN2 stage, cells have to depend on
GATA-3, Notch1/RBPSuh, E box proteins, c-Myb, and Ikaros in order to carry
out T-lineage specification, while Ets factors, TCF-1 or LEF-1, Runx factors, and
probably PU.1 are used in essential supporting roles. Initially, Id2 is expressed
as well, particularly in fetal T cell precursors (63). In other contexts, GATA and
PU.1 factors are mutually antagonistic for erythroid versus myeloid development
(246–248); Notch and E box proteins are antagonists with respect to B cell de-
velopment (249, 250); and Runx and GATA-3 appear to have antagonistic effects
in CD4/CD8 lineage divergence and possibly Th1/Th2 divergence as well, as de-
scribed above. The prolonged coexpression of potential antagonists makes a sharp
contrast with the kind of positive feedback networks seen to drive terminal dif-
ferentiation in Th1 or Th2 cells, or in certain embryonic systems (251). However,
these factors are all used together, and are all genetically required, during these
critical but unstable stages of T cell development.
Overexpression of many of these factors can tilt the balance to a non-T de-
velopmental fate or else block proliferation (Figure 9). As already discussed, the
E protein/Id balance is critical for T cells to develop instead of NK cells, with
Id2 normally promoting the NK fate. However, E proteins block proliferation.
Id2 is essential for NK-cell development, and loss-of-function experiments show
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Figure 9 T-lineage specification by regulatory balance among drivers of competing
developmental options. As discussed in the text, T-lineage specification in the thymus
requires coexpression of factors that promote (PU.1) and inhibit (GATA-3?) the den-
dritic cell or myeloid program, and factors that promote (Id2) and inhibit (E2A/HEB)
the NK cell program, while Notch signaling with a possible contribution from GATA-3
blocks a B cell program that would otherwise be accessible. Of the regulators shown
on this diagram, only EBF and Pax-5 are normally not expressed in early thymocytes,
possibly due to a direct inhibitory influence from Notch/Delta interaction (T. Taghon,
E.-S. David, J.C. Zu´n˜iga-Pflu¨cker & E.V. Rothenberg, submitted). See text for details.
that it is responsible for the NK developmental potential of the most immature
thymocyte subsets (63, 151). Id2 is also associated with development of monocyte/
macrophages and certain classes of dendritic cells, fates that could be promoted
by PU.1 (252–254). Either PU.1 or its relative Spi-B can support dendritic cell de-
velopment. Forced expression of PU.1 blocks T cell development in thymic organ
cultures, with cells arresting in the DN stages and most of the surviving cells show-
ing a myeloid-like phenotype (134; A.H. Weiss & E.V. Rothenberg, unpublished
data). The close relative of PU.1, Spi-B, is highly expressed in dendritic cells, and
its overexpression redirects T cell precursors to full dendritic-cell differentiation
(135; J.M. Lefebvre, M.C. Haks, M.O. Carleton, M. Rhodes, G. Sinnathamby, L.A.
Garrett-Sinha, M.C. Simon, L.C. Eisenlohr, D.L. Wiest, submitted for publication;
D.L. Wiest, personal communication). Notch signaling in some hematopoietic pro-
genitors actually upregulates PU.1 and thus promotes myeloid development (180),
a response that must be restrained in the Notch-dependent T cell precursors.
Even GATA-3 can be problematic for early T cell development. Whereas GATA-
3 may be useful as an antagonist of the dendritic cell and B cell pathways, when
expressed at high levels, it can also be “read” in uncommitted prethymic cells as
a driver of a non-T-lineage fate. In murine bone marrow stem cells, it promotes
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megakaryocyte development inappropriately, while blocking all lymphoid devel-
opment (46), suggesting that it cross-reacts with GATA-1 or GATA-2 target genes.
Not all of these alternative cell types can be kept viable in the thymic microenvi-
ronment, but it is likely that the developmental choices observed there emerge from
fluctuations in the balance of the regulators that are used for T-lineage specification
as well.
In summary, the combination of transcription factors employed for the estab-
lishment of T-lineage identity can be seen as establishing a kind of regulatory
tug-of-war during the stages of initial proliferation. The balance among these
factors itself appears to be critical to maintain the combination of early T cell
gene expression and optimal proliferation. In addition, these cells relinquish their
pluripotentiality only by degrees, and even then, give up non-T alternatives only
to remain capable of a multiplicity of developmental choices within the T lineage,
at later stages of differentiation (Figure 1).
Role of the Microenvironment as a Guide to Commitment
During early T cell development, these potentially diversionary transcription fac-
tors are normally limited to low levels of expression that are not sufficient to redirect
too many thymocytes from the T cell pathway. However, they create a potential
regulatory “hazard” for T-lineage fidelity that can be exacerbated by stimulation.
PU.1 and Spi-B, for example, are strongly enhanced in their transcriptional activity
by phosphorylation or by association with the activation-dependent transcription
factor c-Jun (255–259). Id2 can be induced to high levels by certain kinds of mito-
genic stimulation (reviewed in 260). This could be the mechanism through which
stimulation of fetal thymocytes via FcR crosslinking drives them to differentiate
into NK cells (261).
How do rapidly proliferating DN2 thymocytes avoid these liabilities? Notably,
the IL-7R complex that normally drives most thymocyte expansion prior to com-
mitment is a receptor that is particularly weak at MAP kinase activation (262, 263).
In contrast, the IL-2 receptor β chain CD122, which activates MAP kinases much
better, is confined to precursors that are strongly biased to an NK fate (151, 264).
As a result, IL-2/IL-15R or certain other kinds of growth factor stimulation may
substantially enhance the likelihood of diversion. Stimulation through ectopically
expressed IL-2Rβ (CD122) or GM-CSF receptors can drive the PU.1+ subsets of
thymocytes to monocytic or granulocytic differentiation, without any direct manip-
ulation of PU.1 expression (244, 245). Such extracellular signals only determine
cell fate in convergence with the intracellular regulatory environment, however,
because the PU.1-negative subsets of thymocytes do not respond. Thus, maintain-
ing repression of IL-2Rβ and GM-CSF receptors may be critical throughout the
PU.1-positive stages to keep T-lineage commitment available. At the same time,
maintenance of strong Notch/Delta signaling appears to be important to avoid di-
version to the NK cell lineage throughout the DN1 and DN2 stages, possibly due
to the expression of Id2 by these cells (16).
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Commitment is the stage at which this hazard is finally removed. Ultimately,
the committed cells are ones in which genes such as PU.1 are turned off. Pre-
sumably by this stage at the latest, some of the interaction partners that facilitate
inappropriate effects of GATA-3 are also permanently repressed. Commitment is
also the stage when a new criterion for survival and proliferation is imposed: The
cells lose their ability to survive without signaling through the TCRγ δ or pre-TCR
complex. It thus coincides with the forcible end of the TCR-independent phase of
T cell development. While the basis for this change is not clear yet, it is tempt-
ing to connect it with the extinction of certain stem-cell or pluripotent progenitor
functions. Conversely, the shift in survival requirements can also act as a built-in
quality control for lineage fidelity, for any regulatory perturbation from this point
on that happens to interfere with the TCR complex components or their signal
transduction mediators will now cause cell death.
NEW OPPORTUNITIES: ACCESS TO THE
SPECIFICATION PROCESS IN THE ABSENCE
OF A THYMUS
T-lineage specification emerges from a complex interaction of multiple regulators
of which none plays a simple, dominant role. The gene regulatory network that
controls this process can be clarified only when it is possible to test the effects of
individual perturbations in a focused, stage-specific way. In the past, this has been
a practical challenge due to “black box” aspects of the closed thymic microenvi-
ronment in which so much of T cell specification must take place. Now, however,
a new approach opens up access to cellular and molecular mechanisms operating
in these early stages.
The increased understanding of cues supplied by the thymic microenviron-
ment has made possible an exciting advance in T cell developmental biology. The
OP9-DL1 stromal cell system developed by Zu´n˜iga-Pflu¨cker and coworkers is a
monolayer culture transfected to express Delta-like 1, providing an environment
that supports T cell precursors in the presence of IL-7 and Flt3L. This system pro-
motes T cell development all the way to positive selection from the most primitive
precursors, even from embryonic stem cell lines (16, 26, 265). In this system, the
time course of gene activation from the earliest stages can be tracked and linked
with the time course of developmental potential change (265; T. Taghon, E.-S.
David, J.C. Zu´n˜iga-Pflu¨cker & E.V. Rothenberg, submitted). The reversibility of
these events can be probed as a function of time (T. Taghon, E.-S. David, J.C.
Zu´n˜iga-Pflu¨cker & E.V. Rothenberg, submitted), and the cells can be accessed for
perturbation of the process at any stage.
The quantitative recovery and easy accessibility of precursors in cultures like
these makes it possible for the first time to dissect the molecular control of T-lineage
specification in real time. With the studies based on this new system, future reviews
of the molecular genetics of T cell development will at last be able to illuminate
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 635
the network of specific interactions among regulators and their causal impacts on
developmental change.
ACKNOWLEDGMENTS
Any review like this embodies insights drawn from many people besides the au-
thors themselves. The bibliography understates this debt. We are grateful to many
colleagues for sharing their results and interpretations prior to publication, and we
apologize to the many whose work we were not able to cite, or could cite only in
secondary references. Work in the Rothenberg lab on transcriptional regulation of
T cell development and its evolution was supported by grants from the NIH (R01
CA90233, R01 CA98925) and from NASA (NAG2-1588), with previous support
from NSF (MCB-9983129) and the Stowers Institute for Medical Research.
The Annual Review of Immunology is online at
http://immunol.annualreviews.org
LITERATURE CITED
1. Borowski C, Martin C, Gounari F,
Haughn L, Aifantis I, et al. 2002. On the
brink of becoming a T cell. Curr. Opin.
Immunol. 14:200–6
2. Cantrell DA. 2002. Transgenic analysis of
thymocyte signal transduction. Nat. Rev.
Immunol. 2:20–27
3. Singer A. 2002. New perspectives on a de-
velopmental dilemma: the kinetic signal-
ing model and the importance of signal
duration for the CD4/CD8 lineage deci-
sion. Curr. Opin. Immunol. 14:207–15
4. Alberola-Ila J, Herna´ndez-Hoyos G.
2003. The Ras/MAPK cascade and the
control of positive selection. Immunol.
Rev. 191:79–96
5. Bosselut R. 2004. CD4/CD8-lineage dif-
ferentiation in the thymus: from nuclear
effectors to membrane signals. Nat. Rev.
Immunol. 4:529–40
6. Rothenberg EV, Yui MA, Telfer JC.
2003. T-cell developmental biology. In
Fundamental Immunology, ed. WE Paul,
pp. 259–301. Philadelphia: Lippincott,
Williams & Wilkins
7. Busslinger M. 2004. Transcriptional con-
trol of early B cell development. Annu.
Rev. Immunol. 22:55–79
8. Pear WS, Radtke F. 2003. Notch signal-
ing in lymphopoiesis. Semin. Immunol.
15:69–79
9. Robey EA, Bluestone JA. 2004. Notch
signaling in lymphocyte development and
function. Curr. Opin. Immunol. 16:360–
66
10. Radtke F, Wilson A, Mancini SJ, Mac-
Donald HR. 2004. Notch regulation of
lymphocyte development and function.
Nat. Immunol. 5:247–53
11. Han H, Tanigaki K, Yamamoto N, Kuroda
K, Yoshimoto M, et al. 2002. Inducible
gene knockout of transcription factor
recombination signal binding protein-J
reveals its essential role in T versus B lin-
eage decision. Int. Immunol. 14:637–45
12. Tanigaki K, Tsuji M, Yamamoto N, Han
H, Tsukada J, et al. 2004. Regulation of
αβ/γ δ T cell lineage commitment and pe-
ripheral T cell responses by Notch/RBP-J
signaling. Immunity 20:611–22
13. Wolfer A, Wilson A, Nemir M, MacDon-
ald HR, Radtke F. 2002. Inactivation of
Notch1 impairs VDJβ rearrangement and
allows pre-TCR-independent survival of
early αβ lineage thymocytes. Immunity
5:869–79
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
636 ROTHENBERG  TAGHON
14. Huang EY, Gallegos AM, Richards SM,
Lehar SM, Bevan MJ. 2003. Surface
expression of Notch1 on thymocytes:
correlation with the double-negative to
double-positive transition. J. Immunol.
171:2296–304
15. Ciofani M, Schmitt TM, Ciofani A,
Michie AM, Cuburu N, et al. 2004. Oblig-
atory role for cooperative signaling by
pre-TCR and Notch during thymocyte dif-
ferentiation. J. Immunol. 172:5230–39
16. Schmitt TM, Ciofani M, Petrie HT,
Zu´n˜iga-Pflu¨cker JC. 2004. Maintenance
of T cell specification and differentiation
requires recurrent Notch receptor-ligand
interactions. J. Exp. Med. 200:469–79
17. Choi JW, Pampeno C, Vukmanovic S,
Meruelo D. 2002. Characterization of
the transcriptional expression of Notch-1
signaling pathway members, Deltex and
HES-1, in developing mouse thymocytes.
Dev. Comp. Immunol. 26:575–88
18. Deftos ML, Huang E, Ojala EW, Forbush
KA, Bevan MJ. 2000. Notch1 signaling
promotes the maturation of CD4 and CD8
SP thymocytes. Immunity 13:73–84
19. Bellavia D, Campese AF, Alesse E,
Vacca A, Felli MP, et al. 2000. Con-
stitutive activation of NF-κB and T-cell
leukemia/lymphoma in Notch3 transgenic
mice. EMBO J. 19:3337–48
20. Aster JC, Xu L, Karnell FG, Patriub V,
Pui JC, Pear WS. 2000. Essential roles
for ankyrin repeat and transactivation do-
mains in induction of T-cell leukemia by
Notch1. Mol. Cell. Biol. 20:7505–15
21. Allman D, Karnell FG, Punt JA, Bakkour
S, Xu L, et al. 2001. Separation of
Notch1 promoted lineage commitment
and expansion/transformation in develop-
ing T cells. J. Exp. Med. 194:99–106
22. Deftos ML, Bevan MJ. 2000. Notch sig-
naling in T cell development. Curr. Opin.
Immunol. 12:166–72
23. Basson MA, Zamoyska R. 2000. The
CD4/CD8 lineage decision: integration
of signalling pathways. Immunol. Today
21:509–14
24. Herna´ndez-Hoyos G, Alberola-Ila J.
2003. A Notch so simple influence on
T cell development. Semin. Cell Dev. Biol.
14:121–25
25. Jaleco AC, Neves H, Hooijberg E,
Gameiro P, Clode N, et al. 2001. Differ-
ential effects of Notch ligands Delta-1 and
Jagged-1 in human lymphoid differentia-
tion. J. Exp. Med. 194:991–1002
26. Schmitt TM, Zu´n˜iga-Pflu¨cker JC. 2002.
Induction of T cell development from
hematopoietic progenitor cells by Delta-
like-1 in vitro. Immunity 17:749–56
27. Amsen D, Blander JM, Lee GR, Tanigaki
K, Honjo T, Flavell RA. 2004. Instruc-
tion of distinct CD4 T helper cell fates
by different Notch ligands on antigen-
presenting cells. Cell 117:515–26
28. Yvon ES, Vigouroux S, Rousseau RF,
Biagi E, Amrolia P, et al. 2003. Over ex-
pression of the Notch ligand, Jagged-1
induces alloantigen-specific human regu-
latory T cells. Blood 102:3815–21
29. Maekawa Y, Tsukumo S, Chiba S, Hirai
H, Hayashi Y, et al. 2003. Delta1-Notch3
interactions bias the functional differenti-
ation of activated CD4+ T cells. Immunity
19:549–59
30. Palaga T, Miele L, Golde TE, Osborne
BA. 2003. TCR-mediated Notch signal-
ing regulates proliferation and IFN-γ pro-
duction in peripheral T cells. J. Immunol.
171:3019–24
31. Ting C-N, Olson MC, Barton KP, Leiden
JM. 1996. Transcription factor GATA-3
is required for development of the T-cell
lineage. Nature 384:474–78
32. Hendriks RW, Nawijn MC, Engel JD,
van Doorninck H, Grosveld F, Karis A.
1999. Expression of the transcription fac-
tor GATA-3 is required for the develop-
ment of the earliest T cell progenitors and
correlates with stages of cellular prolif-
eration in the thymus. Eur. J. Immunol.
29:1912–18
33. Samson SI, Richard O, Tavian M, Ranson
T, Vosshenrich CA, et al. 2003. GATA-3
promotes maturation, IFN-γ production,
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 637
and liver-specific homing of NK cells. Im-
munity 19:701–11
34. Hattori N, Kawamoto H, Fujimoto S,
Kuno K, Katsura Y. 1996. Involvement of
transcription factors TCF-1 and GATA-3
in the initiation of the earliest step of T cell
development in the thymus. J. Exp. Med.
184:1137–47
35. Herna´ndez-Hoyos G, Anderson MK,
Wang C, Rothenberg EV, Alberola-Ila J.
2003. GATA-3 expression is controlled by
TCR signals and regulates CD4/CD8 dif-
ferentiation. Immunity 19:83–94
36. Pai SY, Truitt ML, Ting CN, Leiden JM,
Glimcher LH, Ho IC. 2003. Critical roles
for transcription factor GATA-3 in thymo-
cyte development. Immunity 19:863–75
37. Zhang D-H, Yang L, Ray A. 1998. Cut-
ting edge: differential responsiveness of
the IL-5 and IL-4 genes to transcription
factor GATA-3. J. Immunol. 161:3817–21
38. Tripathi RK, Mathieu N, Spicuglia S,
Payet D, Verthuy C, et al. 2000. Defi-
nition of a T-cell receptor β gene core
enhancer of V(D)J recombination by
transgenic mapping. Mol. Cell. Biol. 20:
42–53
39. Kishi H, Wei X-C, Jin Z-X, Fujishiro Y,
Nagata T, et al. 2000. Lineage specific
regulation of the murine RAG-2 promoter:
GATA-3 in T cells and Pax-5 in B cells.
Blood 95:3845–52
40. Lee GR, Fields PE, Flavell RA. 2001.
Regulation of IL-4 gene expression by dis-
tal regulatory elements and GATA-3 at the
chromatin level. Immunity 14:447–59
41. Kieffer LJ, Greally JM, Landres I, Nag S,
Nakajima Y, et al. 2002. Identification of a
candidate regulatory region in the human
CD8 gene complex by colocalization of
DNase I hypersensitive sites and matrix
attachment regions which bind SATB1
and GATA-3. J. Immunol. 168:3915–
22
42. Nawijn MC, Ferreira R, Dingjan GM,
Kahre O, Drabek D, et al. 2001. Enforced
expression of GATA-3 during T cell de-
velopment inhibits maturation of CD8
single-positive cells and induces thymic
lymphoma in transgenic mice. J. Im-
munol. 167:715–23
43. Yamagata T, Mitani K, Oda H, Suzuki
T, Honda H, et al. 2000. Acetylation of
GATA-3 affects T-cell survival and hom-
ing to secondary lymphoid organs. EMBO
J. 19:4676–87
44. Murphy KM, Reiner SL. 2002. The lin-
eage decisions of helper T cells. Nat. Rev.
Immunol. 2:933–44
45. Ho IC, Glimcher LH. 2002. Transcrip-
tion: tantalizing times for T cells. Cell
109(Suppl.):S109–20
46. Chen D, Zhang G. 2001. Enforced expres-
sion of the GATA-3 transcription factor af-
fects cell fate decisions in hematopoiesis.
Exp. Hematol. 29:971–80
47. Anderson MK, Hernandez-Hoyos G,
Dionne CJ, Arias A, Chen D, Rothen-
berg EV. 2002. Definition of regulatory
network elements for T-cell development
by perturbation analysis with PU.1 and
GATA-3. Dev. Biol. 246:103–21
48. Taghon T, De Smedt M, Stolz F, Cnock-
aert M, Plum J, Leclercq G. 2001. En-
forced expression of GATA-3 severely
reduces human thymic cellularity. J. Im-
munol. 167:4468–75
49. Nawijn MC, Dingjan GM, Ferreira R,
Lambrecht BN, Karis A, et al. 2001. En-
forced expression of GATA-3 in trans-
genic mice inhibits Th1 differentiation
and induces the formation of a T1/ST2-
expressing Th2-committed T cell com-
partment in vivo. J. Immunol. 167:724–32
50. Pai SY, Truitt ML, Ho IC. 2004. GATA-3
deficiency abrogates the development and
maintenance of T helper type 2 cells. Proc.
Natl. Acad. Sci. USA 101:1993–98
51. Skapenko A, Leipe J, Niesner U, De-
vriendt K, Beetz R, et al. 2004. GATA-3 in
human T cell helper type 2 development.
J. Exp. Med. 199:423–28
52. Ranganath S, Murphy KM. 2001. Struc-
ture and specificity of GATA proteins in
Th2 development. Mol. Cell Biol. 21:
2716–25
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
638 ROTHENBERG  TAGHON
53. Klein-Hessling S, Jha MK, Santner-
Nanan B, Berberich-Siebelt F, et al.
2003. Protein kinase A regulates GATA-3-
dependent activation of IL-5 gene expres-
sion in Th2 cells. J. Immunol. 170:2956–
61
54. Usui T, Nishikomori R, Kitani A, Strober
W. 2003. GATA-3 suppresses Th1 devel-
opment by downregulation of Stat4 and
not through effects on IL-12Rβ2 chain or
T-bet. Immunity 18:415–28
55. Yin Z, Chen C, Szabo SJ, Glimcher LH,
Ray A, Craft J. 2002. T-Bet expression and
failure of GATA-3 cross-regulation lead to
default production of IFN-γ by γ δ T cells.
J. Immunol. 168:1566–71
56. Lee HJ, Takemoto N, Kurata H, Kamo-
gawa Y, Miyatake S, et al. 2000. GATA-
3 induces T helper cell type 2 (Th2)
cytokine expression and chromatin re-
modeling in committed Th1 cells. J. Exp.
Med. 192:105–15
57. Takemoto N, Arai K, Miyatake S. 2002.
Cutting edge: the differential involvement
of the N-finger of GATA-3 in chromatin
remodeling and transactivation during
Th2 development. J. Immunol. 169:4103–
7
58. Zhou M, Ouyang W, Gong Q, Katz SG,
White JM, et al. 2001. Friend of GATA-1
represses GATA-3-dependent activity in
CD4+ T cells. J. Exp. Med. 194:1461–
71
59. Kurata H, Lee H-J, McClanahan T, Coff-
man RL, O’Garra A, Arai N. 2002. Friend
of GATA is expressed in naive Th cells
and functions as a repressor of GATA-
3-mediated Th2 cell development. J. Im-
munol. 168:4538–45
60. Staal FJT, Weerkamp F, Langerak AW,
Hendriks RW, Clevers HC. 2001. Tran-
scriptional control of T lymphocyte dif-
ferentiation. Stem Cells 19:165–79
61. Greenbaum S, Zhuang Y. 2002. Regu-
lation of early lymphocyte development
by E2A family proteins. Semin. Immunol.
14:405–14
62. Engel I, Murre C. 2001. The function
of E- and Id proteins in lymphocyte de-
velopment. Nat. Rev. Immunol. 1:193–
99
63. Ikawa T, Fujimoto S, Kawamoto H, Kat-
sura Y, Yokota Y. 2001. Commitment to
natural killer cells requires the helix-loop-
helix inhibitor Id2. Proc. Natl. Acad. Sci.
USA 98:5164–69
64. Sawada A, Littman DR. 1993. A het-
erodimer of HEB and an E12-related pro-
tein interacts with the CD4 enhancer and
regulates its activity in T-cell lines. Mol.
Cell. Biol. 13:5620–28
65. Petersson K, Ivars F, Sigvardsson M.
2002. The pTα promoter and enhancer
are direct targets for transactivation by
E box-binding proteins. Eur. J. Immunol.
32:911–20
66. Tremblay M, Herblot S, Lecuyer E,
Hoang T. 2003. Regulation of pTα gene
expression by a dosage of E2A, HEB and
SCL. J. Biol. Chem. 278:12680–87
67. Kee BL, Bain G, Murre C. 2002. IL-7Rα
and E47: independent pathways required
for development of multipotent lymphoid
progenitors. EMBO J. 21:103–13
68. Gre´goire J-M, Rome´o P-H. 1999. T-cell
expression of the human GATA-3 gene
is regulated by a non-lineage specific si-
lencer. J. Biol. Chem. 274:6567–78
69. Heemskerk MHM, Blom B, Nolan G,
Stegmann APA, Bakker AQ, et al. 1997.
Inhibition of T cell and promotion of nat-
ural killer cell development by the domi-
nant negative helix loop helix factor Id3.
J. Exp. Med. 186:1597–602
70. Kim D, Peng X-C, Sun X-H. 1999. Mas-
sive apoptosis of thymocytes in T-cell-
deficient Id1 transgenic mice. Mol. Cell.
Biol. 19:8240–53
71. Pan L, Hanrahan J, Li J, Hale LP, Zhuang
Y. 2002. An analysis of T cell intrinsic
roles of E2A by conditional gene disrup-
tion in the thymus. J. Immunol. 168:3923–
32
72. Barndt RJ, Dai M, Zhuang Y. 2000. Func-
tions of E2A-HEB heterodimers in T-
cell development revealed by a dominant
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 639
negative mutation of HEB. Mol. Cell.
Biol. 20:6677–85
73. Rivera RR, Johns CP, Quan J, Johnson
RS, Murre C. 2000. Thymocyte selection
is regulated by the helix-loop-helix in-
hibitor protein, Id3. Immunity 12:17–26
74. Engel I, Johns C, Bain G, Rivera RR,
Murre C. 2001. Early thymocyte develop-
ment is regulated by modulation of E2A
protein activity. J. Exp. Med. 194:733–46
75. Bain G, Cravatt CB, Loomans C,
Alberola-Ila J, Hedrick SM, Murre C.
2001. Regulation of the helix-loop-helix
proteins, E2A and Id3, by the Ras-ERK
MAPK cascade. Nat. Immunol. 2:165–71
76. Morrow MA, Mayer EW, Perez CA, Ad-
lam M, Siu G. 1999. Overexpression of the
helix-loop-helix protein Id2 blocks T cell
development at multiple stages. Mol. Im-
munol. 36:491–503
77. Engel I, Murre C. 2004. E2A proteins en-
force a proliferation checkpoint in devel-
oping thymocytes. EMBO J. 23:202–11
78. Levanon D, Groner Y. 2004. Structure
and regulated expression of mammalian
RUNX genes. Oncogene 23:4211–19
79. Ichikawa M, Asai T, Saito T, Yamamoto
G, Seo S, et al. 2004. AML-1 is required
for megakaryocytic maturation and lym-
phocytic differentiation, but not for main-
tenance of hematopoietic stem cells in
adult hematopoiesis. Nat. Med. 10:299–
304
80. Anderson MK, Pant R, Miracle AL, Sun
X, Luer CA, et al. 2004. Evolutionary ori-
gins of lymphocytes: ensembles of T cell
and B cell transcriptional regulators in a
cartilaginous fish. J. Immunol. 172:5851–
60
81. Tracey WD, Speck NA. 2000. Potential
roles for RUNX1 and its orthologs in de-
termining hematopoietic cell fate. Semin.
Cell Dev. Biol. 11:337–42
82. Ling KW, Dzierzak E. 2002. Ontogeny
and genetics of the hemato/lymphopoietic
system. Curr. Opin. Immunol. 14:186–91
83. Nishimura M, Fukushima-Nakase Y, Fu-
jita Y, Nakao M, Toda S, et al. 2004.
VWRPY motif-dependent and -indepen-
dent roles of AML1/Runx1 transcription
factor in murine hematopoietic develop-
ment. Blood 103:562–70
84. Telfer JC, Hedblom EE, Anderson MK,
Laurent MN, Rothenberg EV. 2004.
Localization of the domains in Runx tran-
scription factors required for the repres-
sion of CD4 in thymocytes. J. Immunol.
172:4359–70
85. Woolf E, Xiao C, Fainaru O, Lotem J,
Rosen D, et al. 2003. Runx3 and Runx1
are required for CD8 T cell development
during thymopoiesis. Proc. Natl. Acad.
Sci. USA 100:7731–36
86. Taniuchi I, Osato M, Egawa T, Sunshine
MJ, Bae S-C, et al. 2002. Differential re-
quirements for Runx proteins in CD4 re-
pression and epigenetic silencing during T
lymphocyte development. Cell 111:621–
33
87. Vaillant F, Blyth K, Andrew L, Neil JC,
Cameron ER. 2002. Enforced expression
of Runx2 perturbs T cell development at a
stage coincident with β-selection. J. Im-
munol. 169:2866–74
88. Hayashi K, Abe N, Watanabe T, Obinata
M, Ito M, et al. 2001. Overexpression of
AML1 transcription factor drives thymo-
cytes into the CD8 single-positive lineage.
J. Immunol. 167:4957–65
89. Satake M, Nomura S, Yamaguchi-Iwai Y,
Takahama Y, Hashimoto Y, et al. 1995.
Expression of the Runt domain-encoding
PEBP2α genes in T cells during thymic
development. Mol. Cell. Biol. 15:1662–
70
90. Telfer JC, Rothenberg EV. 2001. Expres-
sion and function of a stem-cell promoter
for the murine CBFα2 gene: distinct roles
and regulation in natural killer and T cell
development. Dev. Biol. 229:363–82
91. Hsiang YH, Spencer D, Wang S, Speck
NA, Raulet DH. 1993. The role of viral
enhancer “core” motif-related sequences
in regulating T cell receptor-γ and -δ gene
expression. J. Immunol. 150:3905–16
92. Wotton D, Ghysdael J, Wang S, Speck
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
640 ROTHENBERG  TAGHON
NA, Owen MJ. 1994. Cooperative binding
of Ets-1 and core binding factor to DNA.
Mol. Cell. Biol. 14:840–50
93. Hernandez-Munain C, Krangel MS. 1994.
Regulation of the T-cell receptor δ en-
hancer by functional cooperation between
c-Myb and core-binding factors. Mol.
Cell. Biol. 14:473–83
94. Giese K, Kingsley C, Kirshner JR, Gross-
chedl R. 1995. Assembly and function of a
TCRα enhancer complex is dependent on
LEF-1-induced DNA bending and mul-
tiple protein-protein interactions. Genes
Dev. 9:995–1008
95. Erman B, Cortes M, Nikolajczyk BS,
Speck NA, Sen R. 1998. ETS-core bind-
ing factor: a common composite motif
in antigen receptor gene enhancers. Mol.
Cell. Biol. 18:1322–30
96. Kim W-Y, Sieweke M, Ogawa E, Wee H-
J, Englmeier U, et al. 1999. Mutual activa-
tion of Ets-1 and AML1 DNA binding by
direct interaction of their autoinhibitory
domains. EMBO J. 18:1609–20
97. Yannoutsos N, Barreto V, Misulovin Z,
Gazumyan A, Yu W, et al. 2004. A cis ele-
ment in the recombination activating gene
locus regulates gene expression by coun-
teracting a distant silencer. Nat. Immunol.
5:443–50
98. Ehlers M, Laule-Kilian K, Petter M,
Aldrian CJ, Grueter B, et al. 2003.
Morpholino antisense oligonucleotide-
mediated gene knockdown during thymo-
cyte development reveals role for Runx3
transcription factor in CD4 silencing dur-
ing development of CD4−/CD8+ thymo-
cytes. J. Immunol. 171:3594–604
99. Liu X, Bosselut R. 2004. Duration of TCR
signaling controls CD4-CD8 lineage dif-
ferentiation in vivo. Nat. Immunol. 5:280–
88
99a. Kohu K, Sato T, Ohno S-i, Hayashi K,
Uchino R, et al. 2005. Over-expression of
the Runx3 transcription factor increases
the proportion of mature thymocytes of
the CD8 single positive lineage. J. Im-
munol. In press
100. Komine O, Hayashi K, Natsume W,
Watanabe T, Seki Y, et al. 2003. The
Runx1 transcription factor inhibits the dif-
ferentiation of naive CD4+ T cells into the
Th2 lineage by repressing GATA3 expres-
sion. J. Exp. Med. 198:51–61
101. Cortes M, Wong E, Koipally J, Geor-
gopoulos K. 1999. Control of lymphocyte
development by the Ikaros gene family.
Curr. Opin. Immunol. 11:167–71
102. Brown KE, Guest SS, Smale ST, Hahm K,
Merkenschlager M, Fisher AG. 1997. As-
sociation of transcriptionally silent genes
with Ikaros complexes at centromeric het-
erochromatin. Cell 91:845–54
103. Harker N, Naito T, Cortes M, Hostert A,
Hirschberg S, et al. 2002. The CD8α gene
locus is regulated by the Ikaros family of
proteins. Mol. Cell 10:1403–15
104. Georgopoulos K. 2002. Haematopoietic
cell-fate decisions, chromatin regulation
and Ikaros. Nat. Rev. Immunol. 2:162–74
105. Winandy S, Wu L, Wang J-H, Georgopou-
los K. 1999. Pre-T cell receptor (TCR) and
TCR-controlled checkpoints in T cell dif-
ferentiation are set by Ikaros. J. Exp. Med.
190:1039–48
106. Nichogiannopoulou A, Trevisan M,
Neben S, Friedrich C, Georgopoulos K.
1999. Defects in hemopoietic stem cell
activity in Ikaros mutant mice. J. Exp.
Med. 190:1201–14
107. Papathanasiou P, Perkins AC, Cobb BS,
Ferrini R, Sridharan R, et al. 2003.
Widespread failure of hematolymphoid
differentiation caused by a recessive
niche-filling allele of the Ikaros transcrip-
tion factor. Immunity 19:131–44
108. Allman D, Sambandam A, Kim S, Miller
JP, Pagan A, et al. 2003. Thymopoiesis in-
dependent of common lymphoid progen-
itors. Nat. Immunol. 4:168–74
109. Urban JA, Winandy S. 2004. Ikaros null
mice display defects in T cell selection
and CD4 versus CD8 lineage decision. J.
Immunol. 173:4470–78
110. Chi TH, Wan M, Zhao K, Taniuchi I, Chen
L, et al. 2002. Reciprocal regulation of
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 641
CD4/CD8 expression by SWI/SNF-like
BAF complexes. Nature 418:195–99
111. Okamura RM, Sigvardsson M, Galceran
J, Verbeek S, Clevers H, Grosschedl R.
1998. Redundant regulation of T cell dif-
ferentiation and TCRα gene expression by
the transcription factors LEF-1 and TCF-
1. Immunity 8:11–20
112. Schilham MW, Wilson A, Moerer P,
Benaissa-Trouw BJ, Cumano A, Clevers
HC. 1998. Critical involvement of Tcf-1
in expansion of thymocytes. J. Immunol.
161:3984–91
113. Gounari F, Aifantis I, Khazaie K, Hoe-
flinger S, Harada N, et al. 2001. Somatic
activation of β-catenin bypasses pre-TCR
signaling and TCR selection in thymo-
cyte development. Nat. Immunol. 2:863–
69
114. Ioannidis V, Beermann F, Clevers H, Held
W. 2001. The β-catenin–TCF-1 pathway
ensures CD4+CD8+ thymocyte survival.
Nat. Immunol. 2:691–97
115. Staal FJT, Weerkamp F, Baert MR, van
den Burg CM, van Noort M, et al. 2004.
Wnt target genes identified by DNA mi-
croarrays in immature CD34+ thymocytes
regulate proliferation and cell adhesion. J.
Immunol. 172:1099–108
116. Reya T, Duncan AW, Ailles L, Domen J,
Scherer DC, et al. 2003. A role for Wnt
signalling in self-renewal of haematopoi-
etic stem cells. Nature 423:409–14
117. Allen RD, III, Bender TP, Siu G. 1999.
c-Myb is essential for early T cell devel-
opment. Genes Dev. 13:1073–78
118. Emambokus N, Vegiopoulos A, Harman
B, Jenkinson E, Anderson G, Frampton
J. 2003. Progression through key stages
of haemopoiesis is dependent on dis-
tinct threshold levels of c-Myb. EMBO J.
22:4478–88
119. Mukouyama Y, Chiba N, Mucenski
ML, Satake M, Miyajima A, et al.
1999. Hematopoietic cells in cultures
of the murine embryonic aorta-gonad-
mesonephros region are induced by c-
Myb. Curr. Biol. 9:833–36
120. Hsiang YH, Goldman JP, Raulet DH.
1995. The role of c-Myb or a related fac-
tor in regulating the T cell receptor γ
gene enhancer. J. Immunol. 154:5195–
204
121. Allen RD, III, Kim HK, Sarafova SD, Siu
G. 2001. Negative regulation of CD4 gene
expression by a HES-1-c-Myb complex.
Mol. Cell. Biol. 21:3071–82
122. Herna´ndez-Munain C, Krangel MS. 2002.
Distinct roles for c-Myb and core binding
factor/polyoma enhancer-binding protein
2 in the assembly and function of a mul-
tiprotein complex on the TCR δ enhancer
in vivo. J. Immunol. 169:4362–69
123. Pearson R, Weston K. 2000. c-Myb reg-
ulates the proliferation of immature thy-
mocytes following β-selection. EMBO J.
19:6112–20
124. Bender TP, Kremer CS, Kraus M, Buch T,
Rajewsky K. 2004. Critical functions for
c-Myb at three checkpoints during thymo-
cyte development. Nat. Immunol. 5:721–
29
125. Anderson MK, Hernandez-Hoyos G, Di-
amond RA, Rothenberg EV. 1999. Pre-
cise developmental regulation of Ets
family transcription factors during speci-
fication and commitment to the T cell lin-
eage. Development 126:3131–48
126. Spain LM, Guerriero A, Kunjibettu S,
Scott EW. 1999. T cell development in
PU.1-deficient mice. J. Immunol. 163:
2681–87
127. Herblot S, Steff AM, Hugo P, Aplan PD,
Hoang T. 2000. SCL and LMO1 alter
thymocyte differentiation: inhibition of
E2A-HEB function and pre-Tα chain ex-
pression. Nat. Immunol. 1:138–44
128. Su GH, Ip HS, Cobb BS, Lu M-M, Chen
H-M, Simon MC. 1996. The Ets protein
Spi-B is expressed exclusively in B cells
and T cells during development. J. Exp.
Med. 184:203–14
129. Lloberas J, Soler C, Celada A. 1999. The
key role of PU.1/SPI-1 in B cells, myeloid
cells and macrophages. Immunol. Today
20:184–89
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
642 ROTHENBERG  TAGHON
130. Dahl R, Simon MC. 2003. The impor-
tance of PU.1 concentration in hematopoi-
etic lineage commitment and maturation.
Blood Cells Mol. Dis. 31:229–33
131. Back J, Dierich A, Bronn C, Kastner P,
Chan S. 2004. PU.1 determines the self-
renewal capacity of erythroid progenitor
cells. Blood 103:3615–23
132. DeKoter RP, Lee H-J, Singh H. 2002.
PU.1 regulates expression of the Inter-
leukin-7 receptor in lymphoid progeni-
tors. Immunity 16:297–309
133. McKercher SR, Torbett BE, Anderson
KL, Henkel GW, Vestal DJ, et al. 1996.
Targeted disruption of the PU.1 gene re-
sults in multiple hematopoietic abnormal-
ities. EMBO J. 15:5647–58
134. Anderson MK, Weiss A, Hernandez-
Hoyos G, Dionne CJ, Rothenberg EV.
2002. Constitutive expression of PU.1 in
fetal hematopoietic progenitors blocks T-
cell development at the pro-T stage. Im-
munity 16:285–96
135. Schotte R, Rissoan MC, Bendriss-
Vermare N, Bridon JM, Duhen T, et al.
2003. The transcription factor Spi-B is
expressed in plasmacytoid DC precursors
and inhibits T-, B-, and NK-cell develop-
ment. Blood 101:1015–23
136. Trinh LA, Ferrini R, Cobb BS, Wein-
mann AS, Hahm K, et al. 2001.
Down-regulation of TDT transcription in
CD4+CD8+ thymocytes by Ikaros pro-
teins in direct competition with an Ets ac-
tivator. Genes Dev. 15:1817–32
137. Bories J-C, Willerford DM, Gre´vin D,
Davidson L, Camus A, et al. 1995. In-
creased T-cell apoptosis and terminal
B-cell differentiation induced by inactiva-
tion of the Ets-1 proto-oncogene. Nature
377:635–38
138. Barton K, Muthusamy N, Fischer C, Ting
C-N, Walunas TL, et al. 1998. The Ets-1
transcription factor is required for the de-
velopment of natural killer cells in mice.
Immunity 9:555–63
139. Xue H-H, Bollenbacher J, Rovella V,
Tripuraneni R, Du Y-B, et al. 2004. GA
binding protein regulates interleukin 7 re-
ceptor α-chain gene expression in T cells.
Nat. Immunol. 5:1036–44
140. Sauvageau G, Lansdorp PM, Eaves CJ,
Hogge DE, Dragowska WH, et al. 1994.
Differential expression of homeobox
genes in functionally distinct CD34+ sub-
populations of human bone marrow cells.
Proc. Natl. Acad. Sci. USA 91:12223–27
141. Taghon T, Thys K, De Smedt M,
Weerkamp F, Staal FJ, et al. 2003.
Homeobox gene expression profile in
human hematopoietic multipotent stem
cells and T-cell progenitors: implications
for human T-cell development. Leukemia
17:1157–63
142. Izon DJ, Rozenfeld S, Fong ST, Komuves
L, Largman C, Lawrence HJ. 1998. Loss
of function of the homeobox gene Hoxa-9
perturbs early T-cell development and in-
duces apoptosis in primitive thymocytes.
Blood 92:383–93
143. Szabo SJ, Kim ST, Costa GL, Zhang
X, Fathman CG, Glimcher LH. 2000. A
novel transcription factor, T-bet, directs
Th1 lineage commitment. Cell 100:655–
69
144. Shier P, Hofstra CL, Ma XJ, Wu Y, Ngo
K, Fung-Leung WP. 2000. Tbt-1, a new
T-box transcription factor induced in ac-
tivated Th1 and CD8+ T cells. Immuno-
genetics 51:771–78
145. Mullen AC, High FA, Hutchins AS, Lee
HW, Villarino AV, et al. 2001. Role of
T-bet in commitment of TH1 cells be-
fore IL-12-dependent selection. Science
292:1907–10
146. Pearce EL, Mullen AC, Martins GA,
Krawczyk CM, Hutchins AS, et al. 2003.
Control of effector CD8+ T cell function
by the transcription factor Eomesodermin.
Science 302:1041–43
147. Townsend MJ, Weinmann AS, Matsuda
JL, Salomon R, Farnham PJ, et al. 2004. T-
bet regulates the terminal maturation and
homeostasis of NK and Vα14i NKT Cells.
Immunity 20:477–94
148. Allen JD, Harris AW, Bath ML, Strasser
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 643
A, Scollay R, Adams JM. 1995. Perturbed
development of T and B cells in mice ex-
pressing an Hlx homeobox transgene. J.
Immunol. 154:1531–42
149. Mullen AC, Hutchins AS, High FA, Lee
HW, Sykes KJ, et al. 2002. Hlx is in-
duced by and genetically interacts with
T-bet to promote heritable TH1 gene in-
duction. Nat. Immunol. 3:652–58
150. Zheng WP, Zhao Q, Zhao X, Li B, Hubank
M, et al. 2004. Up-regulation of Hlx in
immature Th cells induces IFN-γ expres-
sion. J. Immunol. 172:114–22
151. Lian RH, Kumar V. 2002. Murine natural
killer cell progenitors and their require-
ments for development. Semin. Immunol.
14:453–60
152. Wilkinson B, Chen JY, Han P, Rufner
KM, Goularte OD, Kaye J. 2002. TOX: an
HMG box protein implicated in the reg-
ulation of thymocyte selection. Nat. Im-
munol. 3:272–80
153. Aliahmad P, O’Flaherty E, Han P,
Goularte OD, Wilkinson B, et al. 2004.
TOX provides a link between calcineurin
activation and CD8 lineage commitment.
J. Exp. Med. 199:1089–99
154. Higashi Y, Moribe H, Takagi T, Sekido R,
Kawakami K, et al. 1997. Impairment of
T cell development in δEF1 mutant mice.
J. Exp. Med. 185:1467–79
155. Postigo AA, Sheppard AM, Mucenski
ML, Dean DC. 1997. c-Myb and Ets
proteins synergize to overcome transcrip-
tional repression by ZEB. EMBO J. 16:
3924–34
156. Jepsen K, Hermanson O, Onami TM,
Gleiberman AS, Lunyak V, et al. 2000.
Combinatorial roles of the nuclear recep-
tor corepressor in transcription and devel-
opment. Cell 102:753–63
157. Hock H, Hamblen MJ, Rooke HM, Traver
D, Bronson RT, et al. 2003. Intrinsic re-
quirement for zinc finger transcription
factor Gfi-1 in neutrophil differentiation.
Immunity 18:109–20
158. Yu¨cel R, Karsunky H, Klein-Hitpass L,
Mo¨ro¨y T. 2003. The transcriptional re-
pressor Gfi1 affects development of early,
uncommitted c-Kit+ T cell progenitors
and CD4/CD8 lineage decision in the thy-
mus. J. Exp. Med. 197:831–44
159. Doan LL, Kitay MK, Yu Q, Singer A,
Herblot S, et al. 2003. Growth factor
independence-1B expression leads to de-
fects in T cell activation, IL-7 receptor
α expression, and T cell lineage commit-
ment. J. Immunol. 170:2356–66
160. Osawa M, Yamaguchi T, Nakamura Y,
Kaneko S, Onodera M, et al. 2002. Ery-
throid expansion mediated by the Gfi-
1B zinc finger protein: role in normal
hematopoiesis. Blood 100:2769–77
161. Saleque S, Cameron S, Orkin SH. 2002.
The zinc-finger proto-oncogene Gfi-1b is
essential for development of the erythroid
and megakaryocytic lineages. Genes Dev.
16:301–6
162. Zhu J, Guo L, Min B, Watson CJ, Hu-Li J,
et al. 2002. Growth factor independent-1
induced by IL-4 regulates Th2 cell prolif-
eration. Immunity 16:733–44
163. Alvarez JD, Yasui DH, Niida H, Joh
T, Loh DY, Kohwi-Shigematsu T. 2000.
The MAR-binding protein SATB1 or-
chestrates temporal and spatial expression
of multiple genes during T-cell develop-
ment. Genes Dev. 14:521–35
164. Cai S, Han H-J, Kohwi-Shigematsu T.
2003. Tissue-specific nuclear architecture
and gene expression regulated by SATB1.
Nat. Genet. 34:42–51
165. Yasui D, Miyano M, Cai S, Varga-Weisz
P, Kohwi-Shigematsu T. 2002. SATB1
targets chromatin remodelling to regu-
late genes over long distances. Nature
419:641–45
166. Fisher AG, Merkenschlager M. 2002.
Gene silencing, cell fate and nuclear or-
ganisation. Curr. Opin. Genet. Dev. 12:
193–97
167. Hardy RR. 2003. B-cell commitment: de-
ciding on the players. Curr. Opin. Im-
munol. 15:158–65
168. Maier H, Hagman J. 2002. Roles of EBF
and Pax-5 in B lineage commitment and
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
644 ROTHENBERG  TAGHON
development. Semin. Immunol. 14:415–
22
169. Medina KL, Pongubala JMR, Reddy KL,
Lancki DW, DeKoter R, et al. 2004. As-
sembling a gene regulatory network for
specification of the B cell fate. Dev. Cell
7:607–17
170. Rosenbauer F, Wagner K, Kutok JL,
Iwasaki H, Akashi K, et al. 2003. Myeloid
and B-lymphoid development require
high PU.1 expression by a distal element
in vivo. Blood 102:342A
171. Ikawa T, Kawamoto H, Wright LY,
Murre C. 2004. Long-term cultured E2A-
deficient hematopoietic progenitor cells
are pluripotent. Immunity 20:349–60
172. Cotta CV, Zhang Z, Kim HG, Klug CA.
2003. Pax5 determines B- versus T-cell
fate and does not block early myeloid-
lineage development. Blood 101:4342–46
173. Seet CS, Brumbaugh RL, Kee BL. 2004.
Early B Cell Factor promotes B lym-
phopoiesis with reduced Interleukin 7 re-
sponsiveness in the absence of E2A. J.
Exp. Med. 199:1689–700
174. Souabni A, Cobaleda C, Schebesta M,
Busslinger M. 2002. Pax5 promotes B
lymphopoiesis and blocks T cell devel-
opment by repressing Notch1. Immunity
17:781–93
175. Zhang Z, Cotta CV, Stephan RP, deGuz-
man CG, Klug CA. 2003. Enforced ex-
pression of EBF in hematopoietic stem
cells restricts lymphopoiesis to the B cell
lineage. EMBO J. 22:4759–69
176. Goebel P, Janney N, Valenzuela JR, Ro-
manow WJ, Murre C, Feeney AJ. 2001.
Localized gene-specific induction of ac-
cessibility to V(D)J recombination in-
duced by E2A and early B cell factor in
nonlymphoid cells. J. Exp. Med. 194:645–
56
177. Smith EM, Gisler R, Sigvardsson M.
2002. Cloning and characterization of a
promoter flanking the early B cell factor
(EBF) gene indicates roles for E-proteins
and autoregulation in the control of EBF
expression. J. Immunol. 169:261–70
178. Gisler R, Sigvardsson M. 2002. The hu-
man V-preB promoter is a target for co-
ordinated activation by early B cell factor
and E47. J. Immunol. 168:5130–38
179. Sayegh CE, Quong MW, Agata Y, Murre
C. 2003. E-proteins directly regulate ex-
pression of activation-induced deaminase
in mature B cells. Nat. Immunol. 4:586–
93
180. Schroeder T, Kohlhof H, Rieber N, Just
U. 2003. Notch signaling induces mul-
tilineage myeloid differentiation and up-
regulates PU.1 expression. J. Immunol.
170:5538–48
181. Aifantis I, Gounari F, Scorrano L,
Borowski C, von Boehmer H. 2001. Con-
stitutive pre-TCR signaling promotes dif-
ferentiation through Ca2+ mobilization
and activation of NF-κB and NFAT. Nat.
Immunol. 2:403–9
182. Carleton M, Haks MC, Smeele SA, Jones
A, Belkowski SM, et al. 2002. Early
growth response transcription factors are
required for development of CD4−CD8−
thymocytes to the CD4+CD8+ stage. J.
Immunol. 168:1649–58
183. Xi H, Kersh GJ. 2004. Early growth
response gene 3 regulates thymocyte
proliferation during the transition from
CD4−CD8− to CD4+CD8+. J. Immunol.
172:964–71
184. Barndt R, Dai MF, Zhang Y. 1999. A
novel role for HEB downstream or parallel
to the pre-TCR signaling pathway during
αβ thymopoiesis. J. Immunol. 163:3331–
43
185. Yasutomo K, Doyle C, Miele L, Ger-
main RN. 2000. The duration of anti-
gen receptor signalling determines CD4+
versus CD8+ T-cell lineage fate. Nature
404:506–10
186. Dunon D, Courtois D, Vainio O, Six A,
Chen CH, et al. 1997. Ontogeny of the im-
mune system: γ /δ and α/β T cells migrate
from thymus to the periphery in alternat-
ing waves. J. Exp. Med. 186:977–88
187. Rast JP, Litman GW. 1998. Towards un-
derstanding the evolutionary origins and
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 645
early diversification of rearranging anti-
gen receptors. Immunol. Rev. 166:79–86
188. Fehling HJ, Gilfillan S, Ceredig R. 1999.
αβ/γ δ lineage commitment in the thy-
mus of normal and genetically manipu-
lated mice. Adv. Immunol. 71:1–76
189. Bruno L, Fehling HJ, von Boehmer H.
1996. The αβ T cell receptor can replace
the γ δ receptor in the development of γ δ
lineage cells. Immunity 5:343–52
190. Dave VP, Cao Z, Browne C, Alarcon B,
Fernandez-Miguel G, et al. 1997. CD3δ
deficiency arrests development of the αβ
but not the γ δ T cell lineage. EMBO J.
16:1360–70
191. Terrence K, Pavlovich CP, Matechak EO,
Fowlkes BJ. 2000. Premature expression
of T cell receptor (TCR)αβ suppresses
TCRγ δ gene rearrangement but permits
development of γ δ lineage T cells. J. Exp.
Med. 192:537–48
192. Lee PP, Fitzpatrick DR, Beard C, Jessup
HK, Lehar S, et al. 2001. A critical role
for Dnmt1 and DNA methylation in T cell
development, function, and survival. Im-
munity 15:763–74
193. Pennington DJ, Silva-Santos B, Shires J,
Theodoridis E, Pollitt C, et al. 2003. The
inter-relatedness and interdependence of
mouse T cell receptor γ δ+ and αβ+ cells.
Nat. Immunol. 4:991–98
194. Washburn T, Schweighoffer E, Gridley T,
Chang D, Fowlkes BJ, et al. 1997. Notch
activity influences the αβ versus γ δ T cell
lineage decision. Cell 88:833–43
195. Bain G, Romanow WJ, Albers K, Havran
WL, Murre C. 1999. Positive and nega-
tive regulation of V(D)J recombination by
the E2A proteins. J. Exp. Med. 189:289–
300
196. Blom B, Heemskerk MHM, Verschuren
MCM, van Dongen JJM, Stegmann APA,
et al. 1999. Disruption of αβ but not of
γ δ T cell development by overexpres-
sion of the helix-loop-helix protein Id3 in
committed T cell progenitors. EMBO J.
18:2793–802
197. De Smedt M, Reynvoet K, Kerre T,
Taghon T, Verhasselt B, et al. 2002. Ac-
tive form of Notch imposes T cell fate
in human progenitor cells. J. Immunol.
169:3021–29
198. Garcia-Peydro M, de Yebenes VG,
Toribio ML. 2003. Sustained Notch1 sig-
naling instructs the earliest human in-
trathymic precursors to adopt a γ δ T cell
fate in fetal thymus organ culture. Blood
102:2444–51
199. Lee C-K, Kim K, Geiman TM, Mur-
phy WJ, Muegge K, Durum SK. 1999.
Cloning thymic precursor cells: demon-
stration that individual pro-T1 cells have
dual T-NK potential and individual pro-
T2 cells have dual αβ−γ δ T cell poten-
tial. Cell Immunol. 191:139–44
200. Lacorazza HD, Miyazaki Y, Di Cristofano
A, Deblasio A, Hedvat C, et al. 2002. The
ETS protein MEF plays a critical role in
perforin gene expression and the devel-
opment of Natural Killer and NK-T cells.
Immunity 17:437–49
201. Ohteki T, Ho S, Suzuki H, Mak TW,
Ohashi PS. 1997. Role for IL-15/IL-15
receptor β-chain in Natural Killer 1.1+
T cell receptor-αβ+ cell development. J.
Immunol. 159:5931–35
202. Ohteki T, Yoshida H, Matsuyama T, Dun-
can GS, Mak TW, Ohashi PS. 1998. The
transcription factor interferon regulatory
factor 1 (IRF-1) is important during the
maturation of Natural Killer 1.1+ T cell
receptor-α/β+ (NK1+ T) cells, natural
killer cells, and intestinal intraepithelial
T cells. J. Exp. Med. 187:967–72
203. Walunas TL, Wang B, Wang CR, Leiden
JM. 2000. Cutting edge: The Ets1 tran-
scription factor is required for the devel-
opment of NK T cells in mice. J. Immunol.
164:2857–60
204. MacDonald HR. 2002. Development and
selection of NKT cells. Curr. Opin. Im-
munol. 14:250–54
205. Ramsdell F. 2003. Foxp3 and natural reg-
ulatory T cells: key to a cell lineage? Im-
munity 19:165–68
206. Harman BC, Jenkinson EJ, Anderson G.
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
646 ROTHENBERG  TAGHON
2003. Entry into the thymic microenviron-
ment triggers Notch activation in the earli-
est migrant T cell progenitors. J. Immunol.
170:1299–303
207. Ivanov V, Merkenschlager M, Ceredig
R. 1993. Antioxidant treatment of thymic
organ cultures decreases NF-κB and
TCF1(α) transcription factor activities
and inhibits αβ T cell development. J. Im-
munol. 151:4694–704
208. Schwarz BA, Bhandoola A. 2004. Circu-
lating hematopoietic progenitors with T
lineage potential. Nat. Immunol. 9:953–
60
209. Kincade PW, Igarashi H, Medina KL,
Kouro T, Yokota T, et al. 2002. Lymphoid
lineage cells in adult murine bone marrow
diverge from those of other blood cells at
an early, hormone-sensitive stage. Semin.
Immunol. 14:385–94
210. Prohaska SS, Scherer DC, Weissman IL,
Kondo M. 2002. Developmental plastic-
ity of lymphoid progenitors. Semin. Im-
munol. 14:377–84
211. Rothenberg EV, Dionne CJ. 2002. Lin-
eage plasticity and commitment in T-
cell development. Immunol. Rev. 187:96–
115
212. Bhandoola A, Sambandam A, Allman D,
Meraz A, Schwarz B. 2003. Early T lin-
eage progenitors: New insights, but old
questions remain. J. Immunol. 171:5653–
58
213. Wang H, Spangrude GJ. 2003. Aspects of
early lymphoid commitment. Curr. Opin.
Hematol. 10:203–7
214. Douagi I, Colucci F, Di Santo JP, Cumano
A. 2002. Identification of the earli-
est prethymic bipotent T/NK progeni-
tor in murine fetal liver. Blood 99:463–
71
215. Kondo M, Weissman IL, Akashi K.
1997. Identification of clonogenic com-
mon lymphoid progenitors in mouse bone
marrow. Cell 91:661–72
216. Martin CH, Aifantis I, Scimone ML,
von Andrian UH, Reizis B, et al. 2003.
Efficient thymic immigration of B220+
lymphoid-restricted bone marrow cells
with T precursor potential. Nat. Immunol.
4:866–73
217. Perry SS, Wang H, Pierce LJ, Yang AM,
Tsai S, Spangrude GJ. 2004. L-Selectin
defines a bone marrow analogue to the
thymic early T-lineage progenitor. Blood
103:2990–96
218. Igarashi H, Gregory SC, Yokota T, Sak-
aguchi N, Kincade PW. 2002. Transcrip-
tion from the RAG1 locus marks the
earliest lymphocyte progenitors in bone
marrow. Immunity 17:117–30
219. Katsura Y. 2002. Redefinition of lym-
phoid progenitors. Nat. Rev. Immunol. 2:
127–32
220. Mebius RE, Miyamoto T, Christensen J,
Domen J, Cupedo T, et al. 2001. The fetal
liver counterpart of adult common lym-
phoid progenitors gives rise to all lym-
phoid lineages, CD45+CD4+CD3− cells,
as well as macrophages. J. Immunol. 166:
6593–601
221. Lu M, Kawamoto H, Katsube Y, Ikawa T,
Katsura Y. 2002. The common myelolym-
phoid progenitor: a key intermediate stage
in hemopoiesis generating T and B cells.
J. Immunol. 169:3519–25
222. Yokota T, Kouro T, Hirose J, Igarashi H,
Garrett KP, et al. 2003. Unique proper-
ties of fetal lymphoid progenitors identi-
fied according to RAG1 gene expression.
Immunity 19:365–75
223. Porritt HE, Rumfelt LL, Tabrizifard S,
Schmitt TM, Zu´n˜iga-Pflu¨cker JC, Petrie
HT. 2004. Heterogeneity among DN1
prothymocytes reveals multiple progeni-
tors with different capacities to generate
T cell and non-T cell lineages. Immunity
20:735–45
224. Fisher RC, Lovelock JD, Scott EW. 1999.
A critical role for PU.1 in homing and
long-term engraftment by hematopoietic
stem cells in the bone marrow. Blood
94:1283–90
225. North TE, de Bruijn MF, Stacy T, Talebian
L, Lind E, et al. 2002. Runx1 ex-
pression marks long-term repopulating
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 647
hematopoietic stem cells in the midgesta-
tion mouse embryo. Immunity 16:661–72
226. Varnum-Finney B, Xu L, Brashem-
Stein C, Nourigat C, Flowers D, et al.
2000. Pluripotent, cytokine-dependent,
hematopoietic stem cells are immortal-
ized by constitutive Notch1 signaling.
Nat. Med. 6:1278–81
227. Sikes ML, Gomez RJ, Song J, Oltz
E. 1998. A developmental stage-specific
promoter directs germline transcription of
DβJβ gene segments in precursor T lym-
phocytes. J. Immunol. 161:1399–405
228. Reizis B, Leder P. 2002. Direct induction
of T lymphocyte-specific gene expression
by the mammalian Notch signaling path-
way. Genes Dev. 16:295–300
229. Allen JM, Forbush KA, Perlmutter RM.
1992. Functional dissection of the lck
proximal promoter. Mol. Cell. Biol. 12:
2758–68
230. McCracken S, Leung S, Bosselut R, Ghys-
dael J, Miyamoto NG. 1994. Myb and Ets
related transcription factors are required
for activity of the human lck type I pro-
moter. Oncogene 9:3609–15
231. Wang Q-F, Lauring J, Schlissel MS. 2000.
c-Myb binds to a sequence in the proximal
region of the RAG-2 promoter and is es-
sential for promoter activity in T-lineage
cells. Mol. Cell. Biol. 20:9203–11
232. Tomita K, Hattori M, Nakamura E,
Nakanishi S, Minato N, Kageyama R.
1999. The bHLH gene Hes1 is essential
for expansion of early T cell precursors.
Genes Dev. 13:1203–10
233. Kawamoto H, Ohmura K, Fujimoto S, Lu
M, Ikawa T, Katsura Y. 2003. Extensive
proliferation of T cell lineage-restricted
progenitors in the thymus: an essential
process for clonal expression of diverse
T cell receptor beta chains. Eur. J. Im-
munol. 33:606–15
234. Shen HQ, Lu M, Ikawa T, Masuda K,
Ohmura K, et al. 2003. T/NK bipotent
progenitors in the thymus retain the po-
tential to generate dendritic cells. J. Im-
munol. 171:3401–6
235. Petrie HT. 2003. Cell migration and the
control of post-natal T-cell lymphopoiesis
in the thymus. Nat. Rev. Immunol. 3:859–
66
236. Rothenberg EV. 2000. Stepwise specifi-
cation of lymphocyte developmental lin-
eages. Curr. Opin. Genet. Dev. 10:370–79
237. Wu L, Li C-L, Shortman K. 1996. Thymic
dendritic cell precursors: relationship to
the T lymphocyte lineage and phenotype
of the dendritic cell progeny. J. Exp. Med.
184:903–11
238. Spits H, Blom B, Jaleco AC, Weijer K,
Verschuren MC, et al. 1998. Early stages
in the development of human T, natural
killer and thymic dendritic cells. Immunol.
Rev. 165:75–86
239. Ikawa T, Kawamoto H, Fujimoto S,
Katsura Y. 1999. Commitment of com-
mon T/natural killer (NK) progenitors to
unipotent T and NK progenitors in the
murine fetal thymus revealed by a single
progenitor assay. J. Exp. Med. 190:1617–
25
240. Michie AM, Carlyle JR, Schmitt TM, Lju-
tic B, Cho SK, et al. 2000. Clonal charac-
terization of a bipotent T cell and NK cell
progenitor in the mouse fetal thymus. J.
Immunol. 164:1730–33
241. Lee C-K, Kim JK, Kim Y, Lee MK, Kim
K, et al. 2001. Generation of macrophages
from early T progenitors in vitro. J. Im-
munol. 166:5964–69
242. Ohishi K, Varnum-Finney B, Serda RE,
Anasetti C, Bernstein ID. 2001. The Notch
ligand, Delta-1, inhibits the differentia-
tion of monocytes into macrophages but
permits their differentiation into dendritic
cells. Blood 98:1402–7
243. Corcoran L, Ferrero I, Vremec D, Lu-
cas K, Waithman J, et al. 2003. The lym-
phoid past of mouse plasmacytoid cells
and thymic dendritic cells. J. Immunol.
170:4926–32
244. King AG, Kondo M, Scherer DC, Weiss-
man IL. 2002. Lineage infidelity in
myeloid cells with TCR gene rearrange-
ment: a latent developmental potential of
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
648 ROTHENBERG  TAGHON
proT cells revealed by ectopic cytokine
receptor signaling. Proc. Natl. Acad. Sci.
USA 99:4508–13
245. Iwasaki-Arai J, Iwasaki H, Miyamoto
T, Watanabe S, Akashi K. 2003. En-
forced Granulocyte/Macrophage Colony-
Stimulating Factor signals do not sup-
port lymphopoiesis, but instruct lymphoid
to myelomonocytic lineage conversion. J.
Exp. Med. 197:1311–22
246. Rekhtman N, Radparvar F, Evans T, Sk-
oultchi A. 1999. Direct interaction of
hematopoietic transcription factors PU.1
and GATA-1: functional antagonism in
erythroid cells. Genes Dev. 13:1398–411
247. Zhang P, Behre G, Pan J, Iwama A,
Wara-Aswapati N, et al. 1999. Negative
cross-talk between hematopoietic regula-
tors: GATA proteins repress PU.1. Proc.
Natl. Acad. Sci. USA 96:8705–10
248. Nerlov C, Querfurth E, Kulessa H, Graf
T. 2000. GATA-1 interacts with the
myeloid PU.1 transcription factor and
represses PU.1-dependent transcription.
Blood 95:2543–51
249. Izon DJ, Aster JC, He Y, Weng A, Kar-
nell FG, et al. 2002. Deltex1 redirects lym-
phoid progenitors to the B cell lineage by
antagonizing Notch1. Immunity 16:231–
43
250. Nie L, Xu M, Vladimirova A, Sun X-H.
2003. Notch-induced E2A ubiquitination
and degradation are controlled by MAP
kinase activities. EMBO J. 22:5780–92
251. Davidson EH, McClay DR, Hood L. 2003.
Regulatory gene networks and the prop-
erties of the developmental process. Proc.
Natl. Acad. Sci. USA 100:1475–80
252. Hacker C, Kirsch RD, Ju X-S, Hierony-
mus T, Gust TC, et al. 2003. Transcrip-
tional profiling identifies Id2 function in
dendritic cell development. Nat. Immunol.
4:380–86
253. Ishiguro A, Spirin KS, Shiohara M, To-
bler A, Gombart AF, et al. 1996. Id2 ex-
pression increases with differentiation of
human myeloid cells. Blood 87:5225–31
254. Cooper CL, Brady G, Bilia F, Iscove
NN, Quesenberry PJ. 1997. Expression
of the Id family helix-loop-helix regula-
tors during growth and development in the
hematopoietic system. Blood 89:3155–65
255. Mao C, Ray-Gallet D, Tavitian A,
Moreau-Gachelin F. 1996. Differential
phosphorylations of Spi-B and Spi-1 tran-
scription factors. Oncogene 12:863–73
256. Rieske P, Pongubala JM. 2001. AKT
induces transcriptional activity of PU.1
through phosphorylation-mediated mod-
ifications within its transactivation do-
main. J. Biol. Chem. 276:8460–68
257. Wang J-M, Lai M-Z, Yang-Yen H-F.
2003. Interleukin-3 stimulation of mcl-
1 gene transcription involves activation
of the PU.1 transcription factor through
a p38 mitogen-activated protein kinase-
dependent pathway. Mol. Cell. Biol. 23:
1896–909
258. Mazzi P, Donini M, Margotto D, Wientjes
F, Dusi S. 2004. IFN-γ induces gp91phox
expression in human monocytes via pro-
tein kinase C-dependent phosphorylation
of PU.1. J. Immunol. 172:4941–47
259. Behre G, Whitmarsh AJ, Coghlan MP,
Hoang T, Carpenter CL, et al. 1999.
c-Jun is a c-Jun NH2-terminal kinase-
independent coactivator of the PU.1
transcription factor. J. Biol. Chem. 274:
4939–46
260. Yokota Y, Mori S. 2002. Role of Id family
proteins in growth control. J. Cell. Phys-
iol. 190:21–28
261. Durum SK, Lee C, Geiman TM, Murphy
WJ, Muegge K. 1998. CD16 cross-linking
blocks rearrangement of the TCRβ lo-
cus and development of αβ T cells and
induces development of NK cells from
thymic progenitors. J. Immunol. 161:
3325–29
262. Gadina M, Sudarshan C, Visconti R, Zhou
YJ, Gu H, et al. 2000. The docking
molecule gab2 is induced by lymphocyte
activation and is involved in signaling by
interleukin-2 and interleukin-15 but not
other common γ chain-using cytokines.
J. Biol. Chem. 275:26959–66
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
19 Feb 2005 14:8 AR AR239-IY23-19.tex XMLPublishSM(2004/02/24) P1: JRX
REGULATION OF T CELL DEVELOPMENT 649
263. Kovanen PE, Rosenwald A, Fu J, Hurt
EM, Lam LT, et al. 2003. Analysis of γ c-
family cytokine target genes. Identifica-
tion of dual-specificity phosphatase 5
(DUSP5) as a regulator of mitogen-
activated protein kinase activity in
interleukin-2 signaling. J. Biol. Chem.
278:5205–13
264. Rosmaraki EE, Douagi I, Roth C, Colucci
F, Cumano A, Di Santo JP. 2001. Identifi-
cation of committed NK cell progenitors
in adult murine bone marrow. Eur. J. Im-
munol. 31:1900–9
265. Schmitt TM, De Pooter RF, Gronski
MA, Cho SK, Ohashi PS, Zu´n˜iga-Pflu¨cker
JC. 2004. Induction of T cell develop-
ment and establishment of T cell compe-
tence from embryonic stem cells differ-
entiated in vitro. Nat. Immunol. 5:410–
17
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: JRX
February 21, 2005 13:52 Annual Reviews AR239-FM
Annual Review of Immunology
Volume 23, 2005
CONTENTS
FRONTISPIECE—Tadamitsu Kishimoto x
INTERLEUKIN-6: FROM BASIC SCIENCE TO MEDICINE–40 YEARS IN
IMMUNOLOGY, Tadamitsu Kishimoto 1
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL
RESPONSES, Tania H. Watts 23
DEVELOPMENT AND REGULATION OF CELL-MEDIATED IMMUNE
RESPONSES TO THE BLOOD STAGES OF MALARIA: IMPLICATIONS
FOR VACCINE RESEARCH, Michael F. Good, Huji Xu, Michelle Wykes,
and Christian R. Engwerda 69
THE T CELL RECEPTOR: CRITICAL ROLE OF THE MEMBRANE
ENVIRONMENT IN RECEPTOR ASSEMBLY AND FUNCTION,
Matthew E. Call and Kai W. Wucherpfennig 101
CHEMOKINES, SPHINGOSINE-1-PHOSPHATE, AND CELL MIGRATION IN
SECONDARY LYMPHOID ORGANS, Jason G. Cyster 127
MARGINAL ZONE B CELLS, Shiv Pillai, Annaiah Cariappa,
and Stewart T. Moran 161
HOW NEUTROPHILS KILL MICROBES, Anthony W. Segal 197
NK CELL RECOGNITION, Lewis L. Lanier 225
IPC: PROFESSIONAL TYPE 1 INTERFERON-PRODUCING CELLS AND
PLASMACYTOID DENDRITIC CELL PRECURSORS, Yong-Jun Liu 275
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY,
Argyrios N. Theofilopoulos, Roberto Baccala, Bruce Beutler,
and Dwight H. Kono 307
PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY,
INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITY,
Cecilia Garlanda, Barbara Bottazzi, Antonio Bastone,
and Alberto Mantovani 337
MAINTENANCE OF SERUM ANTIBODY LEVELS, Rudolf A. Manz,
Anja E. Hauser, Falk Hiepe, and Andreas Radbruch 367
CATERPILLER: A NOVEL GENE FAMILY IMPORTANT IN IMMUNITY,
CELL DEATH, AND DISEASES, Jenny P-Y. Ting
and Beckley K. Davis 387
v
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: JRX
February 21, 2005 13:52 Annual Reviews AR239-FM
vi CONTENTS
B CELL SIGNALING AND TUMORIGENESIS, Hassan Jumaa,
Rudolf W. Hendriks, and Michael Reth 415
THE NOD MOUSE: A MODEL OF IMMUNE DYSREGULATION,
Mark S. Anderson and Jeffrey A. Bluestone 447
ANTIGEN-SPECIFIC MEMORY B CELL DEVELOPMENT,
Louise J. McHeyzer-Williams and Michael G. McHeyzer-Williams 487
THE B7 FAMILY REVISITED, Rebecca J. Greenwald, Gordon J. Freeman,
and Arlene H. Sharpe 515
TEC FAMILY KINASES IN T LYMPHOCYTE DEVELOPMENT AND
FUNCTION, Leslie J. Berg, Lisa D. Finkelstein, Julie A. Lucas,
and Pamela L. Schwartzberg 549
MOLECULAR GENETICS OF T CELL DEVELOPMENT, Ellen V. Rothenberg
and Tom Taghon 601
UNDERSTANDING PRESENTATION OF VIRAL ANTIGENS TO CD8+
T CELLS IN VIVO: THE KEY TO RATIONAL VACCINE DESIGN,
Jonathan W. Yewdell and S.M. Mansour Haeryfar 651
IMMUNOLOGY OF MULTIPLE SCLEROSIS, Mireia Sospedra
and Roland Martin 683
MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY
CELLS: RECENT ADVANCES, Stephen J. Galli, Janet Kalesnikoff,
Michele A. Grimbaldeston, Adrian M. Piliponsky, Cara M.M. Williams,
and Mindy Tsai 749
NETWORK COMMUNICATIONS: LYMPHOTOXINS, LIGHT, AND TNF,
Carl F. Ware 787
ROLE OF C5A IN INFLAMMATORY RESPONSES, Ren-Feng Guo
and Peter A. Ward 821
DNA DEGRADATION IN DEVELOPMENT AND PROGRAMMED CELL
DEATH, Shigekazu Nagata 853
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: PROGRESS
AND PARADOXES, Mitchell Kronenberg 877
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION,
P.R. Taylor, L. Martinez-Pomares, M. Stacey, H-H. Lin, G.D. Brown,
and S. Gordon 901
REGULATION OF LYMPHOID DEVELOPMENT, DIFFERENTIATION, AND
FUNCTION BY THE NOTCH PATHWAY, Ivan Maillard, Terry Fang,
and Warren S. Pear 945
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO,
E. Sergio Trombetta and Ira Mellman 975
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: JRX
February 21, 2005 13:52 Annual Reviews AR239-FM
CONTENTS vii
INDEXES
Subject Index 1029
Cumulative Index of Contributing Authors, Volumes 13–23 1065
Cumulative Index of Chapter Titles, Volumes 13–23 1072
ERRATA
An online log of corrections to Annual Review of Immunology chapters
may be found at http://immunol.annualreviews.org/errata.shtml
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
5.
23
:6
01
-6
49
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
05
/2
0/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
